Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in J Alzheimers Dis

Retrieve available abstracts of 925 articles:
HTML format
Text format



Single Articles


    December 2017
  1. TELL-MARTI G, Puig-Butille JA, Potrony M, Plana E, et al
    A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161113.
    PubMed     Text format     Abstract available


  2. TONNIES E, Trushina E
    Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161088.
    PubMed     Text format     Abstract available


  3. SATHYA M, Moorthi P, Premkumar P, Kandasamy M, et al
    Resveratrol Intervenes in the Cholesterol- and Isoprenoid-Mediated Amyloidogenic Processing of AbetaPP in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161034.
    PubMed     Text format     Abstract available


  4. WANG H, Hong X, Wang Y
    Mitochondrial Repair Effects of Oxygen Treatment on Alzheimer's Disease Model Mice Revealed by Quantitative Proteomics.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161010.
    PubMed     Text format     Abstract available


  5. BASTIAN FO
    Combined Creutzfeldt-Jakob-Jacob/ Alzheimer's Disease Cases are Important in Search for Microbes in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-160999.
    PubMed     Text format     Abstract available


  6. DASHINIMAEV EB, Artyuhov AS, Bolshakov AP, Vorotelyak EA, et al
    Neurons Derived from Induced Pluripotent Stem Cells of Patients with Down Syndrome Reproduce Early Stages of Alzheimer's Disease Type Pathology in vitro.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-160945.
    PubMed     Text format     Abstract available


  7. VAN WAALWIJK VAN DOORN LJ, Gispert JD, Kuiperij HB, Claassen JA, et al
    Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-160668.
    PubMed     Text format     Abstract available


    October 2017
  8. DUMURGIER J, Hanseeuw BJ, Hatling FB, Judge KA, et al
    Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
    J Alzheimers Dis. 2017 Oct 12. doi: 10.3233/JAD-170511.
    PubMed     Text format     Abstract available


  9. GUO R, Fan G, Zhang J, Wu C, et al
    A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 12. doi: 10.3233/JAD-170343.
    PubMed     Text format     Abstract available


  10. SUNDARAM JR, Poore CP, Sulaimee NHB, Pareek T, et al
    Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 12. doi: 10.3233/JAD-170093.
    PubMed     Text format     Abstract available


  11. PATERSON EN, Williams MA, Passmore P, Silvestri G, et al
    Estimated Glomerular Filtration Rate is not Associated with Alzheimer's Disease in a Northern Ireland Cohort.
    J Alzheimers Dis. 2017 Oct 11. doi: 10.3233/JAD-170480.
    PubMed     Text format     Abstract available


  12. JOSHI A, Jimenez E, Mendez MF
    Initial Heart Rate Reactivity to Socioemotional Pictures in Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 11. doi: 10.3233/JAD-170319.
    PubMed     Text format     Abstract available


  13. REIJS BLR, Vos SJB, Soininen H, Lotjonen J, et al
    Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
    J Alzheimers Dis. 2017 Oct 11. doi: 10.3233/JAD-170039.
    PubMed     Text format     Abstract available


  14. MANZINE PR, Pelucchi S, Horst MA, Vale FAC, et al
    microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-170592.
    PubMed     Text format     Abstract available


  15. SWERDLOW RH
    Mitochondria and Mitochondrial Cascades in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-170585.
    PubMed     Text format     Abstract available


  16. BRUNO D
    The Emergence of a New Conceptual Framework for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-170536.
    PubMed     Text format     Abstract available


  17. ZHANG L, Wang Y, Xiayu X, Shi C, et al
    Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-170020.
    PubMed     Text format     Abstract available


  18. SHENG M, Lu H, Liu P, Li Y, et al
    Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 7. doi: 10.3233/JAD-161006.
    PubMed     Text format     Abstract available


  19. TUWAIG M, Savard M, Jutras B, Poirier J, et al
    Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 3. doi: 10.3233/JAD-170545.
    PubMed     Text format     Abstract available


  20. KIRSEBOM BE, Espenes R, Waterloo K, Hessen E, et al
    Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.
    J Alzheimers Dis. 2017 Oct 3. doi: 10.3233/JAD-170385.
    PubMed     Text format     Abstract available


    September 2017
  21. COWAN RL, Beach PA, Atalla SW, Dietrich MS, et al
    Sex Differences in the Psychophysical Response to Contact Heat in Moderate Cognitive Impairment Alzheimer's Disease: A Cross-Sectional Brief Report.
    J Alzheimers Dis. 2017 Sep 29. doi: 10.3233/JAD-170532.
    PubMed     Text format     Abstract available


  22. WARAGAI M, Moriya M, Nojo T
    Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    J Alzheimers Dis. 2017 Sep 29. doi: 10.3233/JAD-170450.
    PubMed     Text format     Abstract available


  23. MCLIMANS KE, Webb JL, Anantharam V, Kanthasamy A, et al
    Peripheral versus Central Index of Metabolic Dysfunction and Associations with Clinical and Pathological Outcomes in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 29. doi: 10.3233/JAD-170263.
    PubMed     Text format     Abstract available


  24. DIFRANCESCO JC, Tremolizzo L, Polonia V, Giussani G, et al
    Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study.
    J Alzheimers Dis. 2017 Sep 28. doi: 10.3233/JAD-170392.
    PubMed     Text format     Abstract available


  25. BLONZ ER
    Alzheimer's Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis.
    J Alzheimers Dis. 2017 Sep 19. doi: 10.3233/JAD-170549.
    PubMed     Text format     Abstract available


  26. MARTINEZ MARTINEZ P, Mielke M
    Sphingolipids in Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2017 Sep 11. doi: 10.3233/JAD-170735.
    PubMed     Text format    


  27. KISHI T, Matsunaga S, Oya K, Nomura I, et al
    Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.
    J Alzheimers Dis. 2017 Sep 11. doi: 10.3233/JAD-170424.
    PubMed     Text format     Abstract available


  28. INUI Y, Ito K, Kato T
    Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
    J Alzheimers Dis. 2017 Sep 11. doi: 10.3233/JAD-170395.
    PubMed     Text format     Abstract available


  29. KARKI R, Tom Kodamullil A, Hofmann-Apitius M
    Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.
    J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-170440.
    PubMed     Text format     Abstract available


  30. PONGAN E, Tillmann B, Leveque Y, Trombert B, et al
    Can Musical or Painting Interventions Improve Chronic Pain, Mood, Quality of Life, and Cognition in Patients with Mild Alzheimer's Disease? Evidence from a Randomized Controlled Trial.
    J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-170410.
    PubMed     Text format     Abstract available


  31. KUTTNER-HIRSHLER Y, Venkatasubramanian PN, Apolinario J, Bonds J, et al
    Brain Biomarkers in Familial Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-170269.
    PubMed     Text format     Abstract available


  32. ZHANG L, Sun C, Jin Y, Gao K, et al
    Dickkopf 3 (Dkk3) Improves Amyloid-beta Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-161254.
    PubMed     Text format     Abstract available


  33. WEISSBERGER GH, Melrose RJ, Fanale CM, Veliz JV, et al
    Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 1. doi: 10.3233/JAD-170420.
    PubMed     Text format     Abstract available


  34. AMORIM JA, Canas PM, Tome AR, Rolo AP, et al
    Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-beta Peptides Modeling Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 1. doi: 10.3233/JAD-170356.
    PubMed     Text format     Abstract available


  35. NIEMANTSVERDRIET E, Ottoy J, Somers C, De Roeck E, et al
    The Cerebrospinal Fluid Abeta1-42/Abeta1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
    J Alzheimers Dis. 2017 Sep 1. doi: 10.3233/JAD-170327.
    PubMed     Text format     Abstract available


  36. POULIN SP, Bergeron D, Dickerson BC
    Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Sep 1. doi: 10.3233/JAD-160767.
    PubMed     Text format     Abstract available


    August 2017
  37. LEVY NOGUEIRA M, Samri D, Epelbaum S, Lista S, et al
    Alzheimer's Disease Diagnosis Relies on a Twofold Clinical-Biological Algorithm: Three Memory Clinic Case Reports.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170574.
    PubMed     Text format     Abstract available


  38. LARSSON SC, Traylor M, Burgess S, Markus HS, et al
    Genetically-Predicted Adult Height an Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170528.
    PubMed     Text format     Abstract available


  39. GIIL LM, Midttun O, Refsum H, Ulvik A, et al
    Kynurenine Pathway Metabolites in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170485.
    PubMed     Text format     Abstract available


  40. PORTBURY SD, Hare DJ, Sgambelloni C, Perronnes K, et al
    Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170322.
    PubMed     Text format     Abstract available


  41. WILLEN K, Sroka A, Takahashi RH, Gouras GK, et al
    Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-beta and Amyloid-beta Protein Precursor with Synapses.
    J Alzheimers Dis. 2017 Aug 30. doi: 10.3233/JAD-170262.
    PubMed     Text format     Abstract available


  42. MORALES I, Cerda-Troncoso C, Andrade V, Maccioni RB, et al
    The Natural Product Curcumin as a Potential Coadjuvant in Alzheimer's Treatment.
    J Alzheimers Dis. 2017 Aug 21. doi: 10.3233/JAD-170354.
    PubMed     Text format     Abstract available


  43. BASSELERIE H, Bracoud L, Zeestraten E, Bouguen E, et al
    Incident Cerebral Microbleeds on Longitudinal 3T MRI with Susceptibility Weight-Imaging Help to Identify Patients with Mild Cognitive Impairment Progressing to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 17. doi: 10.3233/JAD-170470.
    PubMed     Text format     Abstract available


  44. PAOURI E, Tzara O, Zenelak S, Georgopoulos S, et al
    Genetic Deletion of Tumor Necrosis Factor-alpha Attenuates Amyloid-beta Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 17. doi: 10.3233/JAD-170065.
    PubMed     Text format     Abstract available


  45. BEAGLE AJ, Darwish SM, Ranasinghe KG, La AL, et al
    Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia.
    J Alzheimers Dis. 2017 Aug 17. doi: 10.3233/JAD-170031.
    PubMed     Text format     Abstract available


  46. GERSTENECKER A, Hoagey DA, Marson DC, Kennedy KM, et al
    White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170341.
    PubMed     Text format     Abstract available


  47. OIKONOMIDI A, Tautvydaite D, Gholamrezaee MM, Henry H, et al
    Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170335.
    PubMed     Text format     Abstract available


  48. SUGIMOTO T, Nakamura A, Kato T, Iwata K, et al
    Decreased Glucose Metabolism in Medial Prefrontal Areas is Associated with Nutritional Status in Patients with Prodromal and Early Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170257.
    PubMed     Text format     Abstract available


  49. FLADBY T, Palhaugen L, Selnes P, Waterloo K, et al
    Detecting At-Risk Alzheimer's Disease Cases.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170231.
    PubMed     Text format     Abstract available


  50. SANTANGELO R, Cecchetti G, Bernasconi MP, Cardamone R, et al
    Cerebrospinal Fluid Amyloid-beta 42, Total Tau, and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170186.
    PubMed     Text format     Abstract available


  51. CHUNG JK, Plitman E, Nakajima S, Caravaggio F, et al
    The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.
    J Alzheimers Dis. 2017 Aug 16. doi: 10.3233/JAD-170098.
    PubMed     Text format     Abstract available


  52. NAGATA T, Nakajima S, Shinagawa S, Plitman E, et al
    Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study.
    J Alzheimers Dis. 2017 Aug 9. doi: 10.3233/JAD-170412.
    PubMed     Text format     Abstract available


  53. THIBEAU S, McFall GP, Camicioli R, Dixon RA, et al
    Alzheimer's Disease Biomarkers Interactively Influence Physical Activity, Mobility, and Cognition Associations in a Non-Demented Aging Population.
    J Alzheimers Dis. 2017 Aug 8. doi: 10.3233/JAD-170130.
    PubMed     Text format     Abstract available


  54. KOYCHEV I, Gunn RN, Firouzian A, Lawson J, et al
    PET Tau and Amyloid-beta Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2017 Aug 8. doi: 10.3233/JAD-170129.
    PubMed     Text format     Abstract available


  55. KAWALIA SB, Raschka T, Naz M, de Matos Simoes R, et al
    Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data.
    J Alzheimers Dis. 2017 Aug 8. doi: 10.3233/JAD-170011.
    PubMed     Text format     Abstract available


  56. BEHESHTI I, Maikusa N, Daneshmand M, Matsuda H, et al
    Classification of Alzheimer's Disease and Prediction of Mild Cognitive Impairment Conversion Using Histogram-Based Analysis of Patient-Specific Anatomical Brain Connectivity Networks.
    J Alzheimers Dis. 2017 Aug 8. doi: 10.3233/JAD-161080.
    PubMed     Text format     Abstract available


    July 2017
  57. ADAMS SL, Benayoun L, Tilton K, Chavez OR, et al
    Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Jul 29. doi: 10.3233/JAD-170459.
    PubMed     Text format     Abstract available


  58. ZHANG N, Zhang L, Li Y, Gordon ML, et al
    Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Jul 29. doi: 10.3233/JAD-170383.
    PubMed     Text format     Abstract available


  59. LE PAGE A, Lamoureux J, Bourgade K, Frost EH, et al
    Polymorphonuclear Neutrophil Functions are Differentially Altered in Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Jul 29. doi: 10.3233/JAD-170124.
    PubMed     Text format     Abstract available


  60. CAVEDO E, Suppa P, Lange C, Opfer R, et al
    Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheime
    J Alzheimers Dis. 2017 Jul 29. doi: 10.3233/JAD-161108.
    PubMed     Text format     Abstract available


  61. EVGEN'EV MB, Krasnov GS, Nesterova IV, Garbuz DG, et al
    Molecular Mechanisms Underlying Neuroprotective Effect of Intranasal Administration of Human Hsp70 in Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 25. doi: 10.3233/JAD-170398.
    PubMed     Text format     Abstract available


  62. RADAKOVIC R, Starr JM, Abrahams S
    A Novel Assessment and Profiling of Multidimensional Apathy in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 25. doi: 10.3233/JAD-170292.
    PubMed     Text format     Abstract available


  63. LAWRENCE E, Vegvari C, Ower A, Hadjichrysanthou C, et al
    A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2017 Jul 25. doi: 10.3233/JAD-170261.
    PubMed     Text format     Abstract available


  64. HAJIPOUR MJ, Ghasemi F, Aghaverdi H, Raoufi M, et al
    Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces.
    J Alzheimers Dis. 2017 Jul 25. doi: 10.3233/JAD-160206.
    PubMed     Text format     Abstract available


  65. DEFRANCESCO M, Marksteiner J, Kemmler G, Fleischhacker WW, et al
    Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 19. doi: 10.3233/JAD-161135.
    PubMed     Text format     Abstract available


  66. BILGEL M, Koscik RL, An Y, Prince JL, et al
    Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies.
    J Alzheimers Dis. 2017 Jul 18. doi: 10.3233/JAD-170448.
    PubMed     Text format     Abstract available


  67. SHI Y, Gu L, Alsharif AA, Zhang Z, et al
    The Distinction of Amyloid-beta Protein Precursor (AbetaPP) Ratio in Platelet Between Alzheimer's Disease Patients and Controls: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2017 Jul 18. doi: 10.3233/JAD-170253.
    PubMed     Text format     Abstract available


  68. DE BELDER M, Santens P, Sieben A, Fias W, et al
    Impaired Processing of Serial Order Determines Working Memory Impairments in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 17. doi: 10.3233/JAD-170193.
    PubMed     Text format     Abstract available


  69. HONG H, Li Y, Su B
    Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
    J Alzheimers Dis. 2017 Jul 17. doi: 10.3233/JAD-170156.
    PubMed     Text format     Abstract available


  70. ZHANG Y, Wang S, Sui Y, Yang M, et al
    Multivariate Approach for Alzheimer's Disease Detection Using Stationary Wavelet Entropy and Predator-Prey Particle Swarm Optimization.
    J Alzheimers Dis. 2017 Jul 17. doi: 10.3233/JAD-170069.
    PubMed     Text format     Abstract available


  71. SOLFRIZZI V, Custodero C, Lozupone M, Imbimbo BP, et al
    Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review.
    J Alzheimers Dis. 2017 Jul 5. doi: 10.3233/JAD-170248.
    PubMed     Text format     Abstract available


  72. JOHANSSON P, Almqvist EG, Bjerke M, Wallin A, et al
    Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 5. doi: 10.3233/JAD-170226.
    PubMed     Text format     Abstract available


  73. BUSSE C, Anselmi P, Pompanin S, Zorzi G, et al
    Specific Verbal Memory Measures May Distinguish Alzheimer's Disease from Dementia with Lewy Bodies.
    J Alzheimers Dis. 2017 Jul 5. doi: 10.3233/JAD-170154.
    PubMed     Text format     Abstract available


  74. ESQUERDA-CANALS G, Marti-Clua J, Roda AR, Villegas S, et al
    An Intracellular Amyloid-beta/AbetaPP Epitope Correlates with Neurodegeneration in those Neuronal Populations Early Involved in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 4. doi: 10.3233/JAD-170218.
    PubMed     Text format     Abstract available


  75. SANTOS CY, Machan JT, Wu WC, Snyder PJ, et al
    Autonomic Cardiac Function in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 4. doi: 10.3233/JAD-170217.
    PubMed     Text format     Abstract available


  76. GIIL LM, Vedeler CA, Kristoffersen EK, Nordrehaug JE, et al
    Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function.
    J Alzheimers Dis. 2017 Jul 1. doi: 10.3233/JAD-170245.
    PubMed     Text format     Abstract available


  77. MUSZYNSKI P, Kulczynska-Przybik A, Borawska R, Litman-Zawadzka A, et al
    The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 1. doi: 10.3233/JAD-170220.
    PubMed     Text format     Abstract available


  78. DYRBA M, Grothe MJ, Mohammadi A, Binder H, et al
    Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.
    J Alzheimers Dis. 2017 Jul 1. doi: 10.3233/JAD-161197.
    PubMed     Text format     Abstract available


  79. TU S, Spiers HJ, Hodges JR, Piguet O, et al
    Egocentric versus Allocentric Spatial Memory in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jul 1. doi: 10.3233/JAD-160592.
    PubMed     Text format     Abstract available


    June 2017
  80. VALERO J, Bernardino L, Cardoso F, Silva AP, et al
    Impact of Neuroinflammation on Hippocampal Neurogenesis: Relevance to Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 28. doi: 10.3233/JAD-170239.
    PubMed     Text format     Abstract available


  81. SERRANO-POZO A, Aldridge GM, Zhang Q
    Four Decades of Research in Alzheimer's Disease (1975-2014): A Bibliometric and Scientometric Analysis.
    J Alzheimers Dis. 2017 Jun 27. doi: 10.3233/JAD-170184.
    PubMed     Text format     Abstract available


  82. CACCIAMANI F, Tandetnik C, Gagliardi G, Bertin H, et al
    Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 26. doi: 10.3233/JAD-170399.
    PubMed     Text format     Abstract available


  83. ZAFAR S, Shafiq M, Younas N, Schmitz M, et al
    Prion Protein Interactome: Identifying Novel Targets in Slowly and Rapidly Progressive Forms of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 26. doi: 10.3233/JAD-170237.
    PubMed     Text format     Abstract available


  84. MICHALSKI D, Hofmann S, Pitsch R, Grosche J, et al
    Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies.
    J Alzheimers Dis. 2017 Jun 26. doi: 10.3233/JAD-170185.
    PubMed     Text format     Abstract available


  85. VASAVADA MM, Martinez B, Wang J, Eslinger PJ, et al
    Central Olfactory Dysfunction in Alzheimer's Disease and Mild Cognitive Impairment: A Functional MRI Study.
    J Alzheimers Dis. 2017 Jun 24. doi: 10.3233/JAD-170310.
    PubMed     Text format     Abstract available


  86. IACCARINO L, Chiotis K, Alongi P, Almkvist O, et al
    A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    J Alzheimers Dis. 2017 Jun 24. doi: 10.3233/JAD-170158.
    PubMed     Text format     Abstract available


  87. BAGATTINI C, Mazza V, Panizza L, Ferrari C, et al
    Neural Dynamics of Multiple Object Processing in Mild Cognitive Impairment and Alzheimer's Disease: Future Early Diagnostic Biomarkers?
    J Alzheimers Dis. 2017 Jun 24. doi: 10.3233/JAD-161274.
    PubMed     Text format     Abstract available


  88. BELLANTI F, Iannelli G, Blonda M, Tamborra R, et al
    Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 24. doi: 10.3233/JAD-160942.
    PubMed     Text format     Abstract available


  89. VASQUEZ JB, Simpson JF, Harpole R, Estus S, et al
    Alzheimer's Disease Genetics and ABCA7 Splicing.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170872.
    PubMed     Text format     Abstract available


  90. STOCCORO A, Siciliano G, Migliore L, Coppede F, et al
    Decreased Methylation of the Mitochondrial D-Loop Region in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170139.
    PubMed     Text format     Abstract available


  91. PADALA KP, Padala PR, Lensing SY, Dennis RA, et al
    Home-Based Exercise Program Improves Balance and Fear of Falling in Community-Dwelling Older Adults with Mild Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170120.
    PubMed     Text format     Abstract available


  92. ASIH PR, Tegg ML, Sohrabi H, Carruthers M, et al
    Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-161259.
    PubMed     Text format     Abstract available


  93. TRIPODIS Y, Alosco ML, Zirogiannis N, Gavett BE, et al
    The Effect of Traumatic Brain Injury History with Loss of Consciousness on Rate of Cognitive Decline Among Older Adults with Normal Cognition and Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-160585.
    PubMed     Text format     Abstract available


  94. LEHRER S, Rheinstein PH, Rosenzweig KE
    Association of Radon Background and Total Background Ionizing Radiation with Alzheimer's Disease Deaths in U.S. States.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170308.
    PubMed     Text format     Abstract available


  95. XIE F, Peng F
    Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.
    J Alzheimers Dis. 2017 Jun 22. doi: 10.3233/JAD-170280.
    PubMed     Text format     Abstract available


  96. BABILONI C, Del Percio C, Lizio R, Noce G, et al
    Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study.
    J Alzheimers Dis. 2017 Jun 10. doi: 10.3233/JAD-160883.
    PubMed     Text format     Abstract available


  97. CANSEV M, Turkyilmaz M, Sijben JWC, Sevinc C, et al
    Synaptic Membrane Synthesis in Rats Depends on Dietary Sufficiency of Vitamin C, Vitamin E, and Selenium: Relevance for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 9. doi: 10.3233/JAD-170081.
    PubMed     Text format     Abstract available


  98. ANAND S, Barnes JM, Young SA, Garcia DM, et al
    Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer's Disease Using Direct Infusion Mass Spectrometry.
    J Alzheimers Dis. 2017 Jun 9. doi: 10.3233/JAD-170035.
    PubMed     Text format     Abstract available


  99. ADEGOKE OO, Qiao F, Liu Y, Longley K, et al
    Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-beta Accumulation in Mice.
    J Alzheimers Dis. 2017 Jun 8. doi: 10.3233/JAD-170173.
    PubMed     Text format     Abstract available


  100. WILKINS HM, Mahnken JD, Welch P, Bothwell R, et al
    A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial.
    J Alzheimers Dis. 2017 Jun 7. doi: 10.3233/JAD-170077.
    PubMed     Text format     Abstract available


  101. NAGAI M, Dote K, Kato M, Sasaki S, et al
    Visit-to-Visit Blood Pressure Variability and Alzheimer's Disease: Links and Risks.
    J Alzheimers Dis. 2017 Jun 7. doi: 10.3233/JAD-161172.
    PubMed     Text format     Abstract available


  102. YU Q, Du F, Douglas JT, Yu H, et al
    Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    J Alzheimers Dis. 2017 Jun 6. doi: 10.3233/JAD-170283.
    PubMed     Text format     Abstract available


  103. GONZALEZ-MACIEL A, Reynoso-Robles R, Torres-Jardon R, Mukherjee PS, et al
    Combustion-Derived Nanoparticles in Key Brain Target Cells and Organelles in Young Urbanites: Culprit Hidden in Plain Sight in Alzheimer's Disease Development.
    J Alzheimers Dis. 2017 Jun 3. doi: 10.3233/JAD-170012.
    PubMed     Text format     Abstract available


  104. DILLEN KNH, Jacobs HIL, Kukolja J, Richter N, et al
    Functional Disintegration of the Default Mode Network in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 3. doi: 10.3233/JAD-161120.
    PubMed     Text format     Abstract available


  105. ANDREADOU E, Pantazaki AA, Daniilidou M, Tsolaki M, et al
    Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jun 3. doi: 10.3233/JAD-161020.
    PubMed     Text format     Abstract available


    May 2017
  106. FERGUSON SA, Panos JJ, Sloper D, Varma V, et al
    Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-170204.
    PubMed     Text format     Abstract available


  107. LUPTON MK, Benyamin B, Proitsi P, Nyholt DR, et al
    No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-170027.
    PubMed     Text format     Abstract available


  108. LIN FV, Wang X, Wu R, Rebok GW, et al
    Identification of Successful Cognitive Aging in the Alzheimer's Disease Neuroimaging Initiative Study.
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-161278.
    PubMed     Text format     Abstract available


  109. BINOSHA FWMAD, Somaratne G, Williams S, Goozee KG, et al
    Diabetes and Alzheimer's Disease: Can Tea Phytochemicals Play a Role in Prevention?
    J Alzheimers Dis. 2017 May 30. doi: 10.3233/JAD-161200.
    PubMed     Text format     Abstract available


  110. SHAW ME, Abhayaratna WP, Anstey KJ, Cherbuin N, et al
    Increasing Body Mass Index at Midlife is Associated with Increased Cortical Thinning in Alzheimer's Disease-Vulnerable Regions.
    J Alzheimers Dis. 2017 May 26. doi: 10.3233/JAD-170055.
    PubMed     Text format     Abstract available


  111. NAVE S, Doody RS, Boada M, Grimmer T, et al
    Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).
    J Alzheimers Dis. 2017 May 26. doi: 10.3233/JAD-161309.
    PubMed     Text format     Abstract available


  112. OCHOA JF, Alonso JF, Duque JE, Tobon CA, et al
    Precuneus Failures in Subjects of the PSEN1 E280A Family at Risk of Developing Alzheimer's Disease Detected Using Quantitative Electroencephalography.
    J Alzheimers Dis. 2017 May 26. doi: 10.3233/JAD-161291.
    PubMed     Text format     Abstract available


  113. MACEDO AC, Balouch S, Tabet N
    Is Sleep Disruption a Risk Factor for Alzheimer's Disease?
    J Alzheimers Dis. 2017 May 26. doi: 10.3233/JAD-161287.
    PubMed     Text format     Abstract available


  114. MORRIS K J, Uy RAZ, Vidoni ED, Wilkins HM, et al
    Effect of APOE epsilon4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-170148.
    PubMed     Text format     Abstract available


  115. CERMAKOVA P, Nelson M, Secnik J, Garcia-Ptacek S, et al
    Living Alone with Alzheimer's Disease: Data from SveDem, the Swedish Dementia Registry.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-170102.
    PubMed     Text format     Abstract available


  116. TRIPATHI AK, Karmakar S, Asthana A, Ashok A, et al
    Transport of Non-Transferrin Bound Iron to the Brain: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-170097.
    PubMed     Text format     Abstract available


  117. PINNER E, Gruper Y, Ben Zimra M, Kristt D, et al
    CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-161245.
    PubMed     Text format     Abstract available


  118. LIU CY, Ohki Y, Tomita T, Osawa S, et al
    Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-161203.
    PubMed     Text format     Abstract available


  119. DETERS KD, Risacher SL, Kim S, Nho K, et al
    Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-161114.
    PubMed     Text format     Abstract available


  120. NAKAMURA N, Ohyagi Y, Imamura T, Yanagihara YT, et al
    Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 25. doi: 10.3233/JAD-160344.
    PubMed     Text format     Abstract available


  121. SIEDLAK SL, Jiang Y, Huntley ML, Wang L, et al
    TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170190.
    PubMed     Text format     Abstract available


  122. TANG M, Taghibiglou C
    The Mechanisms of Action of Curcumin in Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170188.
    PubMed     Text format     Abstract available


  123. OLIVEIRA J, Costa M, de Almeida MSC, da Cruz E Silva OAB, et al
    Protein Phosphorylation is a Key Mechanism in Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170176.
    PubMed     Text format     Abstract available


  124. LIU G, Sun JY, Xu M, Yang XY, et al
    SORL1 Variants Show Different Association with Early-Onset and Late-Onset Alzheimer's Disease Risk.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-170005.
    PubMed     Text format     Abstract available


  125. CALDERON-GARCIDUENAS L, de la Monte SM
    Apolipoprotein E4, Gender, Body Mass Index, Inflammation, Insulin Resistance, and Air Pollution Interactions: Recipe for Alzheimer's Disease Development in Mexico City Young Females.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-161299.
    PubMed     Text format     Abstract available


  126. VEGA IE, Cabrera LY, Wygant CM, Velez-Ortiz D, et al
    Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-161261.
    PubMed     Text format     Abstract available


  127. DOUGHERTY RJ, Schultz SA, Kirby TK, Boots EA, et al
    Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-161067.
    PubMed     Text format     Abstract available


  128. MUSAEUS CS, Shafi MM, Santarnecchi E, Herman ST, et al
    Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 17. doi: 10.3233/JAD-160742.
    PubMed     Text format     Abstract available


  129. SALA I, Illan-Gala I, Alcolea D, Sanchez-Saudinos MB, et al
    Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 13. doi: 10.3233/JAD-170073.
    PubMed     Text format     Abstract available


  130. SUN H
    Associations of Spatial Disparities of Alzheimer's Disease Mortality Rates and Soil Selenium, Sulfur Concentrations, and Risk Factors in the United States.
    J Alzheimers Dis. 2017 May 13. doi: 10.3233/JAD-170059.
    PubMed     Text format     Abstract available


  131. BEN JEMAA S, Attia Romdhane N, Bahri-Mrabet A, Jendli A, et al
    An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
    J Alzheimers Dis. 2017 May 11. doi: 10.3233/JAD-170222.
    PubMed     Text format     Abstract available


  132. JIN WS, Bu XL, Wang YR, Li L, et al
    Reduced Cardiovascular Functions in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 11. doi: 10.3233/JAD-170088.
    PubMed     Text format     Abstract available


  133. ZHU JB, Tan CC, Tan L, Yu JT, et al
    State of Play in Alzheimer's Disease Genetics.
    J Alzheimers Dis. 2017 May 11. doi: 10.3233/JAD-170062.
    PubMed     Text format     Abstract available


  134. CHUNG JK, Plitman E, Nakajima S, Caravaggio F, et al
    Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-170201.
    PubMed     Text format     Abstract available


  135. SNOW WM, Dale R, O'Brien-Moran Z, Buist R, et al
    In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-170136.
    PubMed     Text format     Abstract available


  136. EDSBAGGE M, Andreasson U, Ambarki K, Wikkelso C, et al
    Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-161257.
    PubMed     Text format     Abstract available


  137. ORGETA V, Tabet N, Nilforooshan R, Howard R, et al
    Efficacy of Antidepressants for Depression in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-161247.
    PubMed     Text format     Abstract available


  138. TORT-MERINO A, Valech N, Penaloza C, Gronholm-Nyman P, et al
    Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-161173.
    PubMed     Text format     Abstract available


  139. MANOCHA GD, Ghatak A, Puig KL, Kraner SD, et al
    NFATc2 Modulates Microglial Activation in the AbetaPP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 8. doi: 10.3233/JAD-151203.
    PubMed     Text format     Abstract available


  140. NELSON TJ, Sun MK, Lim C, Sen A, et al
    Bryostatin Effects on Cognitive Function and PKCvarepsilon in Alzheimer's Disease Phase IIa and Expanded Access Trials.
    J Alzheimers Dis. 2017 May 2. doi: 10.3233/JAD-170161.
    PubMed     Text format     Abstract available


  141. PASQUINI L, Benson G, Grothe MJ, Utz L, et al
    Individual Correspondence of Amyloid-beta and Intrinsic Connectivity in the Posterior Default Mode Network Across Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2017 May 2. doi: 10.3233/JAD-170096.
    PubMed     Text format     Abstract available


  142. YOSHINO Y, Yamazaki K, Ozaki Y, Sao T, et al
    INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2017 May 2. doi: 10.3233/JAD-161211.
    PubMed     Text format     Abstract available


    April 2017
  143. MACDONALD IR, Maxwell SP, Reid GA, Cash MK, et al
    Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170164.
    PubMed     Text format     Abstract available


  144. LACOSTA AM, Insua D, Badi H, Pesini P, et al
    Neurofibrillary Tangles of Abetax-40 in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170163.
    PubMed     Text format     Abstract available


  145. BABULAL GM, Stout SH, Head D, Holtzman DM, et al
    Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170067.
    PubMed     Text format     Abstract available


  146. KOLAROVA M, Sengupta U, Bartos A, Ricny J, et al
    Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170048.
    PubMed     Text format     Abstract available


  147. SUN J, Zhou H, Bai F, Zhang Z, et al
    Remyelination: A Potential Therapeutic Strategy for Alzheimer's Disease?
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-170036.
    PubMed     Text format     Abstract available


  148. SEGAL-GAVISH H, Danino O, Barhum Y, Ben-Zur T, et al
    A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161236.
    PubMed     Text format     Abstract available


  149. MALEK-AHMADI M, Lu S, Chan Y, Perez SE, et al
    Cognitive Domain Dispersion Association with Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161233.
    PubMed     Text format     Abstract available


  150. SADIQ D, Whitfield T, Lee L, Stevens T, et al
    Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161089.
    PubMed     Text format     Abstract available


  151. SEPEHRY AA, Lee PE, Hsiung GR, Beattie BL, et al
    The 2002 NIMH Provisional Diagnostic Criteria for Depression of Alzheimer's Disease (PDC-dAD): Gauging their Validity over a Decade Later.
    J Alzheimers Dis. 2017 Apr 28. doi: 10.3233/JAD-161061.
    PubMed     Text format     Abstract available


  152. YAMAZAKI C, Tamaoki T, Nunomura A, Tamai K, et al
    Plasma Amyloid-beta and Alzheimer's Disease-Related Changes in Late-Life Depression.
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-170111.
    PubMed     Text format     Abstract available


  153. LAKEY-BEITIA J, Gonzalez Y, Doens D, Stephens DE, et al
    Assessment of Novel Curcumin Derivatives as Potent Inhibitors of Inflammation and Amyloid-beta Aggregation in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-170071.
    PubMed     Text format     Abstract available


  154. HARDING A, Robinson S, Crean SJ, Singhrao SK, et al
    Can Better Management of Periodontal Disease Delay the Onset and Progression of Alzheimer's Disease?
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-170046.
    PubMed     Text format     Abstract available


  155. TAN YJ, Ng ASL, Vipin A, Lim JKW, et al
    Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-161277.
    PubMed     Text format     Abstract available


  156. YILMAZ A, Geddes T, Han B, Bahado-Singh RO, et al
    Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.
    J Alzheimers Dis. 2017 Apr 25. doi: 10.3233/JAD-161226.
    PubMed     Text format     Abstract available


  157. LI K, Chan W, Doody RS, Quinn J, et al
    Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data.
    J Alzheimers Dis. 2017 Apr 18. doi: 10.3233/JAD-161201.
    PubMed     Text format     Abstract available


  158. PAOLACCI L, Giannandrea D, Mecocci P, Parnetti L, et al
    Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No?
    J Alzheimers Dis. 2017 Apr 15. doi: 10.3233/JAD-161127.
    PubMed     Text format     Abstract available


  159. VIANA JNM, Bittlinger M, Gilbert F
    Ethical Considerations for Deep Brain Stimulation Trials in Patients with Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 15. doi: 10.3233/JAD-161073.
    PubMed     Text format     Abstract available


  160. REDDY PH
    A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 10. doi: 10.3233/JAD-170256.
    PubMed     Text format     Abstract available


  161. YUAN XZ, Sun S, Tan CC, Yu JT, et al
    The Role of ADAM10 in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 10. doi: 10.3233/JAD-170061.
    PubMed     Text format     Abstract available


  162. REDDY PH, Manczak M, Yin X
    Mitochondria-Division Inhibitor 1 Protects Against Amyloid-beta induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 10. doi: 10.3233/JAD-170051.
    PubMed     Text format     Abstract available


  163. ALONSO R, Pisa D, Aguado B, Carrasco L, et al
    Identification of Fungal Species in Brain Tissue from Alzheimer's Disease by Next-Generation Sequencing.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-170058.
    PubMed     Text format     Abstract available


  164. XIE B, Liu Z, Liu W, Jiang L, et al
    DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-170007.
    PubMed     Text format     Abstract available


  165. GARCIA B, Martin C, Olivia GS, Muniz-Alonso B, et al
    Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-161298.
    PubMed     Text format     Abstract available


  166. KEHOE PG, Hibbs E, Palmer LE, Miners JS, et al
    Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-beta and Tau Pathology.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-161265.
    PubMed     Text format     Abstract available


  167. GARCIA A, Mathur S, Kalaw MC, McAvoy E, et al
    Quantitative 3D Telomeric Imaging of Buccal Cells Reveals Alzheimer's Disease-Specific Signatures.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-161169.
    PubMed     Text format     Abstract available


  168. NGUYEN MF, Bonnefoy M, Adrait A, Gueugnon M, et al
    Efficacy of Hearing Aids on the Cognitive Status of Patients with Alzheimer's Disease and Hearing Loss: A Multicenter Controlled Randomized Trial.
    J Alzheimers Dis. 2017 Apr 3. doi: 10.3233/JAD-160793.
    PubMed     Text format     Abstract available


    March 2017
  169. BOHLKEN J, Jacob L, Kostev K
    Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-170091.
    PubMed     Text format     Abstract available


  170. LOPEZ-FONT I, Boix CP, Zetterberg H, Blennow K, et al
    Alterations in the Balance of Amyloid-beta Protein Precursor Species in the Cerebrospinal Fluid of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161275.
    PubMed     Text format     Abstract available


  171. CRAFT S, Claxton A, Baker LD, Hanson AJ, et al
    Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161256.
    PubMed     Text format     Abstract available


  172. ROBB C, Udeh-Momoh C, Wagenpfeil S, Schope J, et al
    Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161162.
    PubMed     Text format     Abstract available


  173. JIANG C, Li G, Huang P, Liu Z, et al
    The Gut Microbiota and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161141.
    PubMed     Text format     Abstract available


  174. JIANG S, Bhaskar K
    Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161123.
    PubMed     Text format     Abstract available


  175. WILLIAMS SM, Schulz P, Rosenberry TL, Caselli RJ, et al
    Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-161116.
    PubMed     Text format     Abstract available


  176. OCHMANN S, Dyrba M, Grothe MJ, Kasper E, et al
    Does Functional Connectivity Provide a Marker for Cognitive Rehabilitation Effects in Alzheimer's Disease? An Interventional Study.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-160773.
    PubMed     Text format     Abstract available


  177. DOREY E, Bamji-Mirza M, Najem D, Li Y, et al
    Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-beta-Induced Inflammatory Response in vivo and in vitro.
    J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-160133.
    PubMed     Text format     Abstract available


  178. LIU XJ, Wei J, Shang YH, Huang HC, et al
    Modulation of AbetaPP and GSK3beta by Endoplasmic Reticulum Stress and Involvement in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 20. doi: 10.3233/JAD-161111.
    PubMed     Text format     Abstract available


  179. BRUEGGEN K, Kasper E, Ochmann S, Pfaff H, et al
    Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-170771.
    PubMed     Text format     Abstract available


  180. HUANG CC, Isidoro C
    Raman Spectrometric Detection Methods for Early and Non-Invasive Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-161238.
    PubMed     Text format     Abstract available


  181. REED C, Happich M, Argimon JM, Haro JM, et al
    What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-160449.
    PubMed     Text format     Abstract available


  182. BRUEGGEN K, Kasper E, Ochmann S, Pfaff H, et al
    Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial.
    J Alzheimers Dis. 2017 Mar 18. doi: 10.3233/JAD-160771.
    PubMed     Text format     Abstract available


  183. ALOSCO ML, Duskin J, Besser LM, Martin B, et al
    Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.
    J Alzheimers Dis. 2017 Mar 13. doi: 10.3233/JAD-161205.
    PubMed     Text format     Abstract available


  184. PIEVANI M, Pini L, Ferrari C, Pizzini FB, et al
    Coordinate-Based Meta-Analysis of the Default Mode and Salience Network for Target Identification in Non-Invasive Brain Stimulation of Alzheimer's Disease and Behavior Variant Frontotemporal Dementia Networks.
    J Alzheimers Dis. 2017 Mar 13. doi: 10.3233/JAD-161105.
    PubMed     Text format     Abstract available


  185. ESQUERDA-CANALS G, Montoliu-Gaya L, Guell-Bosch J, Villegas S, et al
    Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-170045.
    PubMed     Text format     Abstract available


  186. BAROCCO F, Spallazzi M, Concari L, Gardini S, et al
    The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-161264.
    PubMed     Text format     Abstract available


  187. BEYDOUN MA, Gamaldo AA, Beydoun HA, Shaked D, et al
    Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-161225.
    PubMed     Text format     Abstract available


  188. HATASHITA S, Wakebe D
    Amyloid-beta Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-161074.
    PubMed     Text format     Abstract available


  189. GARCIA-CASAL JA, Goni-Imizcoz M, Perea-Bartolome MV, Soto-Perez F, et al
    The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-160940.
    PubMed     Text format     Abstract available


  190. MASON EJ, Hussey EP, Molitor RJ, Ko PC, et al
    Family History of Alzheimer's Disease is Associated with Impaired Perceptual Discrimination of Novel Objects.
    J Alzheimers Dis. 2017 Mar 10. doi: 10.3233/JAD-160772.
    PubMed     Text format     Abstract available


  191. DALLAIRE-THEROUX C, Callahan BL, Potvin O, Saikali S, et al
    Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.
    J Alzheimers Dis. 2017 Mar 6. doi: 10.3233/JAD-161028.
    PubMed     Text format     Abstract available


  192. BOUVY WH, Kuijf HJ, Zwanenburg JJ, Koek HL, et al
    Abnormalities of Cerebral Deep Medullary Veins on 7 Tesla MRI in Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2017 Mar 6. doi: 10.3233/JAD-160952.
    PubMed     Text format     Abstract available


  193. ZHANG C, Zhang Y, Shen Y, Zhao G, et al
    Anesthesia/Surgery Induces Cognitive Impairment Only in Female Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-161268.
    PubMed     Text format     Abstract available


  194. DE MARCO M, Duzzi D, Meneghello F, Venneri A, et al
    Cognitive Efficiency in Alzheimer's Disease is Associated with Increased Occipital Connectivity.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-161164.
    PubMed     Text format     Abstract available


  195. RUB U, Stratmann K, Heinsen H, Seidel K, et al
    Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.
    J Alzheimers Dis. 2017 Mar 2. doi: 0.3233/JAD-161102.
    PubMed     Text format     Abstract available


  196. HANE FT, Robinson M, Lee BY, Bai O, et al
    Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-160907.
    PubMed     Text format     Abstract available


  197. ADRAIT A, Perrot X, Nguyen MF, Gueugnon M, et al
    Do Hearing Aids Influence Behavioral and Psychological Symptoms of Dementia and Quality of Life in Hearing Impaired Alzheimer's Disease Patients and Their Caregivers?
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-160792.
    PubMed     Text format     Abstract available


  198. VAN DER VEN A, Pape J, Hermann D, Schloesser R, et al
    Methylene Blue (Tetramethylthionine Chloride) Influences the Mobility of Adult Neural Stem Cells: A Potentially Novel Therapeutic Mechanism of a Therapeutic Approach in the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-160755.
    PubMed     Text format     Abstract available


  199. KETTER N, Brashear HR, Bogert J, Di J, et al
    Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Mar 2. doi: 10.3233/JAD-160216.
    PubMed     Text format     Abstract available


    February 2017
  200. DONG J, Qin W, Wei C, Tang Y, et al
    A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-beta Production and Tau Phosphorylation.
    J Alzheimers Dis. 2017 Feb 28. doi: 10.3233/JAD-161188.
    PubMed     Text format     Abstract available


  201. ANDREWS SJ, Das D, Anstey KJ, Easteal S, et al
    Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.
    J Alzheimers Dis. 2017 Feb 28. doi: 10.3233/JAD-160774.
    PubMed     Text format     Abstract available


  202. BLONIECKI V, Aarsland D, Blennow K, Cummings J, et al
    Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.
    J Alzheimers Dis. 2017 Feb 28. doi: 10.3233/JAD-160758.
    PubMed     Text format     Abstract available


  203. OBERACHER H, Arnhard K, Linhart C, Diwo A, et al
    Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?
    J Alzheimers Dis. 2017 Feb 28. doi: 10.3233/JAD-160172.
    PubMed     Text format     Abstract available


  204. RIANCHO J, Vazquez-Higuera JL, Pozueta A, Lage C, et al
    MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    J Alzheimers Dis. 2017 Feb 25. doi: 10.3233/JAD-161179.
    PubMed     Text format     Abstract available


  205. PREMA A, Justin Thenmozhi A, Manivasagam T, Mohamed Essa M, et al
    Fenugreek Seed Powder Attenuated Aluminum Chloride-Induced Tau Pathology, Oxidative Stress, and Inflammation in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 25. doi: 10.3233/JAD-161103.
    PubMed     Text format     Abstract available


  206. TOEPPER M
    Dissociating Normal Aging from Alzheimer's Disease: A View from Cognitive Neuroscience.
    J Alzheimers Dis. 2017 Feb 25. doi: 10.3233/JAD-161099.
    PubMed     Text format     Abstract available


  207. DELGADO-GONZALEZ JC, Florensa-Vila J, Mansilla-Legorburo F, Insausti R, et al
    Magnetic Resonance Imaging and Anatomical Correlation of Human Temporal Lobe Landmarks, in 3D Euclidean Space: A Study of Control and Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2017 Feb 25. doi: 10.3233/JAD-160944.
    PubMed     Text format     Abstract available


  208. ROBINSON M, Lee BY, Hane FT
    Recent Progress in Alzheimer's Disease Research, Part 2: Genetics and Epidemiology.
    J Alzheimers Dis. 2017 Feb 16. doi: 10.3233/JAD-161149.
    PubMed     Text format     Abstract available


  209. GONZALES EB, Sumien N
    Acidity and Acid-Sensing Ion Channels in the Normal and Alzheimer's Disease Brain.
    J Alzheimers Dis. 2017 Feb 15. doi: 10.3233/JAD-161131.
    PubMed     Text format     Abstract available


  210. KANDIMALLA R, Reddy PH
    Therapeutics of Neurotransmitters in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 15. doi: 10.3233/JAD-161118.
    PubMed     Text format     Abstract available


  211. EL HAJ M, Gallouj K, Antoine P
    Google Calendar Enhances Prospective Memory in Alzheimer's Disease: A Case Report.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161283.
    PubMed     Text format     Abstract available


  212. YAMAZAKI K, Yoshino Y, Mori T, Yoshida T, et al
    Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161195.
    PubMed     Text format     Abstract available


  213. WANG J, Liu Y, Cheng X, Zhang X, et al
    The Effects of LW-AFC on the Hippocampus Transcriptome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161079.
    PubMed     Text format     Abstract available


  214. MARIONI RE, Campbell A, Hagenaars SP, Nagy R, et al
    Genetic Stratification to Identify Risk Groups for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161070.
    PubMed     Text format     Abstract available


  215. LINDEMER ER, Greve DN, Fischl B, Augustinack JC, et al
    Differential Regional Distribution of Juxtacortical White Matter Signal Abnormalities in Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-161057.
    PubMed     Text format     Abstract available


  216. YANG J, Zhang R, Shi C, Mao C, et al
    AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-160957.
    PubMed     Text format     Abstract available


  217. NAKAYAMA S, Suda A, Nakanishi H, Motoi Y, et al
    Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-160902.
    PubMed     Text format     Abstract available


  218. HANE FT, Lee BY, Leonenko Z
    Recent Progress in Alzheimer's Disease Research, Part 1: Pathology.
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-160882.
    PubMed     Text format     Abstract available


  219. CARDOSO BR, Hare DJ, Bush AI, Li QX, et al
    Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL).
    J Alzheimers Dis. 2017 Feb 10. doi: 10.3233/JAD-160622.
    PubMed     Text format     Abstract available


  220. MONROE TB, Beach PA, Bruehl SP, Dietrich MS, et al
    The Impact of Alzheimer's Disease on the Resting State Functional Connectivity of Brain Regions Modulating Pain: A Cross Sectional Study.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161187.
    PubMed     Text format     Abstract available


  221. BALIETTI M, Giuli C, Fattoretti P, Fabbietti P, et al
    Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161168.
    PubMed     Text format     Abstract available


  222. IENCA M, Fabrice J, Elger B, Caon M, et al
    Intelligent Assistive Technology for Alzheimer's Disease and Other Dementias: A Systematic Review.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161037.
    PubMed     Text format     Abstract available


  223. WANG Q, Li WX, Dai SX, Guo YC, et al
    Meta-Analysis of Parkinson's Disease and Alzheimer's Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161032.
    PubMed     Text format     Abstract available


  224. BAAZAOUI N, Flory M, Iqbal K
    Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-160845.
    PubMed     Text format     Abstract available


  225. KALLIO EL, Ohman H, Kautiainen H, Hietanen M, et al
    Cognitive Training Interventions for Patients with Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-160810.
    PubMed     Text format     Abstract available


  226. SANIN GN, Benke T
    Bimanual Gesture Imitation in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-160680.
    PubMed     Text format     Abstract available


  227. STOCCORO A, Tannorella P, Salluzzo MG, Ferri R, et al
    The Methylenetetrahydrofolate Reductase C677T Polymorphism and Risk for Late-Onset Alzheimer's disease: Further Evidence in an Italian Multicenter Study.
    J Alzheimers Dis. 2017 Feb 7. doi: 10.3233/JAD-161081.
    PubMed     Text format     Abstract available


  228. CHANG KJ, Hong CH, Lee KS, Kang DR, et al
    Mortality Risk after Diagnosis of Early-Onset Alzheimer's Disease versus Late-Onset Alzheimer's Disease: A Propensity Score Matching Analysis.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161181.
    PubMed     Text format     Abstract available


  229. CASTELLANO CA, Paquet N, Dionne IJ, Imbeault H, et al
    A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161163.
    PubMed     Text format     Abstract available


  230. YU L, Wilson RS, Schneider JA, Bennett DA, et al
    Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161132.
    PubMed     Text format     Abstract available


  231. JIA J, Wei C, Jia L, Tang Y, et al
    Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161117.
    PubMed     Text format     Abstract available


  232. GRANHOLM EL, Panizzon MS, Elman JA, Jak AJ, et al
    Pupillary Responses as a Biomarker of Early Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-161078.
    PubMed     Text format     Abstract available


  233. LU Y, Dong Y, Tucker D, Wang R, et al
    Treadmill Exercise Exerts Neuroprotection and Regulates Microglial Polarization and Oxidative Stress in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-160869.
    PubMed     Text format     Abstract available


  234. TIMMERS M, Barao S, Van Broeck B, Tesseur I, et al
    BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-160829.
    PubMed     Text format     Abstract available


  235. LI L, Xu S, Liu L, Feng R, et al
    Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-alpha and IL-1beta in an Abeta25-35-induced Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Feb 1. doi: 10.3233/JAD-160587.
    PubMed     Text format     Abstract available


    January 2017
  236. SUHONEN NM, Hallikainen I, Hanninen T, Jokelainen J, et al
    The Modified Frontal Behavioral Inventory (FBI-mod) for Patients with Frontotemporal Lobar Degeneration, Alzheimer's Disease, and Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Jan 20. doi: 10.3233/JAD-160983.
    PubMed     Text format     Abstract available


  237. EBEL DL, Torkilsen CG, Ostrowski TD
    Blunted Respiratory Responses in the Streptozotocin-Induced Alzheimer's Disease Rat Model.
    J Alzheimers Dis. 2017 Jan 20. doi: 10.3233/JAD-160974.
    PubMed     Text format     Abstract available


  238. HORVATH A, Szucs A, Barcs G, Kamondi A, et al
    Sleep EEG Detects Epileptiform Activity in Alzheimer's Disease with High Sensitivity.
    J Alzheimers Dis. 2017 Jan 19. doi: 10.3233/JAD-160994.
    PubMed     Text format     Abstract available


  239. N'SONGO A, Carrasquillo MM, Wang X, Nguyen T, et al
    Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants.
    J Alzheimers Dis. 2017 Jan 19. doi: 10.3233/JAD-161185.
    PubMed     Text format     Abstract available


  240. GOMEZ-RAMOS A, Picher AJ, Garcia E, Garrido P, et al
    Validation of Suspected Somatic Single Nucleotide Variations in the Brain of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2017 Jan 19. doi: 10.3233/JAD-161053.
    PubMed     Text format     Abstract available


  241. FERRARI L, Huang SC, Magnani G, Ambrosi A, et al
    Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160886.
    PubMed     Text format     Abstract available


  242. LOEWENSTEIN DA, Curiel RE, Wright C, Sun X, et al
    Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160881.
    PubMed     Text format     Abstract available


  243. SUNDERMANN EE, Biegon A, Rubin LH, Lipton RB, et al
    Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer's Disease Pathology in Women versus Men?
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160716.
    PubMed     Text format     Abstract available


  244. HADDICK PC, Larson JL, Rathore N, Bhangale TR, et al
    A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2017 Jan 18. doi: 10.3233/JAD-160524.
    PubMed     Text format     Abstract available


  245. KHAN W, Giampietro V, Banaschewski T, Barker GJ, et al
    A Multi-Cohort Study of ApoE varepsilon4 and Amyloid-beta Effects on the Hippocampus in Alzheimer's Disease.
    J Alzheimers Dis. 2017;56:1159-1174.
    PubMed     Text format     Abstract available


  246. IWAHARA N, Hisahara S, Kawamata J, Matsumura A, et al
    Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
    J Alzheimers Dis. 2017;55:1235-1247.
    PubMed     Text format     Abstract available



  247. Shi-Jiang Li, PhD, Recipient of 2017 Alzheimer Award.
    J Alzheimers Dis. 2017;59:387-388.
    PubMed     Text format    


  248. LOMBARDI G, Berti V, Tedde A, Bagnoli S, et al
    Low Florbetapir PET Uptake and Normal Abeta1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.
    J Alzheimers Dis. 2017;57:697-703.
    PubMed     Text format     Abstract available


  249. IENCA M, Jotterand F, Elger B, Caon M, et al
    Intelligent Assistive Technology for Alzheimer's Disease and Other Dementias: A Systematic Review.
    J Alzheimers Dis. 2017;60:333.
    PubMed     Text format    



  250. Mini-Forum on Sphingolipids in Alzheimer's Disease and Related Disorders, Guest Editors: Michelle Mielke and Pilar Martinez.
    J Alzheimers Dis. 2017;60:751.
    PubMed     Text format    


  251. SERRA L, Gabrielli GB, Tuzzi E, Spano B, et al
    Damage to the Frontal Aslant Tract Accounts for Visuo-Constructive Deficits in Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:1015-1024.
    PubMed     Text format     Abstract available


  252. AHMED ME, Iyer S, Thangavel R, Kempuraj D, et al
    Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
    J Alzheimers Dis. 2017;60:1143-1160.
    PubMed     Text format     Abstract available


  253. HUOVINEN J, Helisalmi S, Paananen J, Laitera T, et al
    Alzheimer's Disease-Related Polymorphisms in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2017;60:1077-1085.
    PubMed     Text format     Abstract available


  254. REIJS BLR, Ramakers IHGB, Elias-Sonnenschein L, Teunissen CE, et al
    Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.
    J Alzheimers Dis. 2017;60:1025-1034.
    PubMed     Text format     Abstract available


  255. COSTA AS, Agostini S, Guerini FR, Mancuso R, et al
    Modulation of Immune Responses to Herpes Simplex Virus Type 1 by IFNL3 and IRF7 Polymorphisms: A Study in Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:1055-1063.
    PubMed     Text format     Abstract available


  256. SANCHEZ SM, Abulafia C, Duarte-Abritta B, de Guevara MSL, et al
    Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:1183-1193.
    PubMed     Text format     Abstract available


  257. PALMIERI G, Cocca E, Gogliettino M, Valentino R, et al
    Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer's Disease: A Sign of Defective Proteostasis?
    J Alzheimers Dis. 2017;60:1097-1106.
    PubMed     Text format     Abstract available


  258. CHEN Y, Sillaire AR, Dallongeville J, Skrobala E, et al
    Low Prevalence and Clinical Effect of Vascular Risk Factors in Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:1045-1054.
    PubMed     Text format     Abstract available


  259. VAKALOPOULOS C
    Alzheimer's Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline.
    J Alzheimers Dis. 2017;60:859-866.
    PubMed     Text format     Abstract available


  260. STEVENSON A, Lopez D, Khoo P, Kalaria RN, et al
    Exploring Erythrocytes as Blood Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2017;60:845-857.
    PubMed     Text format     Abstract available


  261. MISE A, Yoshino Y, Yamazaki K, Ozaki Y, et al
    TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2017;60:1107-1117.
    PubMed     Text format     Abstract available


  262. FINGER E, Zhang J, Dickerson B, Bureau Y, et al
    Disinhibition in Alzheimer's Disease is Associated with Reduced Right Frontal Pole Cortical Thickness.
    J Alzheimers Dis. 2017;60:1161-1170.
    PubMed     Text format     Abstract available


  263. DOS SANTOS MATIOLI MNP, Suemoto CK, Rodriguez RD, Farias DS, et al
    Diabetes is Not Associated with Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2017;60:1035-1043.
    PubMed     Text format     Abstract available


  264. REIJS BLR, Ramakers IHGB, Kohler S, Teunissen CE, et al
    Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.
    J Alzheimers Dis. 2017;60:1119-1128.
    PubMed     Text format     Abstract available


    December 2016
  265. LEE HK, Kwon B, Lemere CA, de la Monte S, et al
    mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-beta Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-161029.
    PubMed     Text format     Abstract available


  266. YARCHOAN M, James BD, Shah RC, Arvanitakis Z, et al
    Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160977.
    PubMed     Text format     Abstract available


  267. BRANDSCHEID C, Schuck F, Reinhardt S, Schafer KH, et al
    Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160926.
    PubMed     Text format     Abstract available


  268. MIELKE MM, Haughey NJ, Han D, An Y, et al
    The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160925.
    PubMed     Text format     Abstract available


  269. SUGIMOTO T, Yoshida M, Ono R, Murata S, et al
    Frontal Lobe Function Correlates with One-Year Incidence of Urinary Incontinence in Elderly with Alzheimer Disease.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160923.
    PubMed     Text format     Abstract available


  270. BERGLAND AK, Dalen I, Larsen AI, Aarsland D, et al
    Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160847.
    PubMed     Text format     Abstract available


  271. CHIDLOW G, Wood JP, Manavis J, Finnie J, et al
    Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160823.
    PubMed     Text format     Abstract available


  272. GARERI P, Castagna A, Cotroneo AM, Putignano D, et al
    The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160808.
    PubMed     Text format     Abstract available


  273. SU F, Shu H, Ye Q, Xie C, et al
    Integration of Multilocus Genetic Risk into the Default Mode Network Longitudinal Trajectory during the Alzheimer's Disease Process.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160787.
    PubMed     Text format     Abstract available


  274. CAROTENUTO A, Rea R, Traini E, Fasanaro AM, et al
    The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160675.
    PubMed     Text format     Abstract available


  275. GAUBERT M, Villain N, Landeau B, Mezenge F, et al
    Neural Correlates of Self-Reference Effect in Early Alzheimer's Disease.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-160561.
    PubMed     Text format     Abstract available


  276. TAN L, Yang H, Pang W, Li H, et al
    Investigation on the Role of BDNF in the Benefits of Blueberry Extracts for the Improvement of Learning and Memory in Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-151108.
    PubMed     Text format     Abstract available


  277. SLOT RE, Van Harten AC, Kester MI, Jongbloed W, et al
    Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
    J Alzheimers Dis. 2016 Dec 30. doi: 10.3233/JAD-151068.
    PubMed     Text format     Abstract available


  278. SQUITTI R, Mendez AJ, Simonelli I, Ricordi C, et al
    Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  279. BENUSSI L, Ghidoni R, Dal Piaz F, Binetti G, et al
    The level of 24-Hydroxycholesteryl Esters is an Early Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  280. MATIAS-GUIU JA, Curiel RE, Rognoni T, Valles-Salgado M, et al
    Validation of the Spanish Version of the LASSI-L for Diagnosing Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  281. DORAN E, Keator D, Head E, Phelan MJ, et al
    Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  282. SABBAGH MN, Schauble B, Anand K, Richards D, et al
    Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  283. SIEGEL AM, Barrett MS, Bhati MT
    Deep Brain Stimulation for Alzheimer's Disease: Ethical Challenges for Clinical Research.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  284. XIE B, Xu Y, Liu Z, Liu W, et al
    Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  285. KOPONEN M, Taipale H, Lavikainen P, Tanskanen A, et al
    Risk of Mortality associated with Antipsychotic Monotherapy and Polypharmacy among Community-Dwelling Persons with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  286. HO L, Legere M, Li T, Levine S, et al
    Autonomic Nervous System Dysfunctions as a Basis for a Predictive Model of Risk of Neurological Disorders in Subjects with Prior History of Traumatic Brain Injury: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  287. SHEN L, Liao L, Chen C, Guo Y, et al
    Proteomics Analysis of Blood Serums from Alzheimer's Disease Patients Using iTRAQ Labeling Technology.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  288. MCLIMANS KE, Willette AA
    Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  289. LAW LL, Schultz SA, Boots EA, Einerson JA, et al
    Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    November 2016
  290. BOCCARDI V, Baroni M, Smirne N, Clodomiro A, et al
    Short-Term Response is not Predictive of Long-Term Response to Acetylcholinesterase Inhibitors in Old Age Subjects with Alzheimer's Disease: A "Real World" Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  291. LI X, Westman E, Thordardottir S, Stahlbom AK, et al
    The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  292. SOKOLOW S, Li X, Chen L, D Taylor K, et al
    Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  293. SANCESARIO GM, Toniolo S, Chiasserini D, Di Santo SG, et al
    The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  294. LAMPELA P, Tolppanen AM, Tanskanen A, Tiihonen J, et al
    Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  295. SHEN L, Liu L, Ji HF
    Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  296. CHONG JR, Chai YL, Lee JH, Howlett D, et al
    Increased Transforming Growth Factor beta2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Abeta42 Load.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  297. SENNIK S, Schweizer TA, Fischer CE, Munoz DG, et al
    Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  298. MATSUDA T, Hisatsune T
    Cholinergic Modification of Neurogenesis and Gliosis Improves the Memory of AbetaPPswe/PSEN1dE9 Alzheimer's Disease Model Mice Fed a High-Fat Diet.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  299. WANG E, Zhu H, Wang X, Gower A, et al
    Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  300. FUJISHIMA M, Kawaguchi A, Maikusa N, Kuwano R, et al
    Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  301. BOADA M, Anaya F, Ortiz P, Olazaran J, et al
    Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-beta Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  302. LOUWERSHEIMER E, Cohn-Hokke PE, Pijnenburg YA, Weiss MM, et al
    Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-varepsilon4 Homozygosity.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  303. PANDYA S, Kuceyeski A, Raj A
    The Brain's Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  304. GLOZMAN T, Solomon J, Pestilli F, Guibas L, et al
    Shape-Attributes of Brain Structures as Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  305. MORGAN AR, Touchard S, O'Hagan C, Sims R, et al
    The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  306. SLACHEVSKY A, Guzman-Martinez L, Delgado C, Reyes P, et al
    Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  307. KIM M, Nevado-Holgado A, Whiley L, Snowden SG, et al
    Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  308. AMEN DG, Darmal B, Raji CA, Bao W, et al
    Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer's Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  309. BEHESHTI I, Maikusa N, Matsuda H, Demirel H, et al
    Histogram-Based Feature Extraction from Individual Gray Matter Similarity-Matrix for Alzheimer's Disease Classification.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  310. ABU RUMEILEH S, Lattanzio F, Stanzani Maserati M, Rizzi R, et al
    Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Abeta42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  311. CAGNIN A, Fragiacomo F, Camporese G, Turco M, et al
    Sleep-Wake Profile in Dementia with Lewy Bodies, Alzheimer's Disease, and Normal Aging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  312. QUARMLEY M, Moberg PJ, Mechanic-Hamilton D, Kabadi S, et al
    Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  313. BERGERON D, Vermette A, De La Sablonniere J, Cayer AM, et al
    Finger-to-Nose Test Findings in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  314. MULLER S, Preische O, Heymann P, Elbing U, et al
    Diagnostic Value of a Tablet-Based Drawing Task for Discrimination of Patients in the Early Course of Alzheimer's Disease from Healthy Individuals.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  315. SZABLEWSKI L
    Glucose Transporters in Brain: In Health and in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  316. CARMONA-IRAGUI M, Santos T, Videla S, Fernandez S, et al
    Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  317. ALVES SARNO T, Leme Talib L, Passarelli Giroud Joaquim H, Farid Gattaz W, et al
    Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  318. ARROYO-ANLLO EM, Boustonb AT, Fargeau MN, Orgaz Baz B, et al
    Self-Consciousness Deficits in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  319. MOSS DE, Perez RG, Kobayashi H
    Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  320. GAMIR-MORRALLA A, Belbin O, Fortea J, Alcolea D, et al
    Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  321. MONACELLI F, Cea M, Borghi R, Odetti P, et al
    Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  322. REITER K, Nielson KA, Durgerian S, Woodard JL, et al
    Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  323. CHAU SA, Herrmann N, Sherman C, Chung J, et al
    Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  324. LUSARDI TA, Phillips JI, Wiedrick JT, Harrington CA, et al
    MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  325. DENGLER-CRISH CM, Smith MA, Wilson GN
    Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  326. BEESLEY S, Olcese J, Saunders C, Bienkiewicz EA, et al
    Combinatorial Treatment Effects in a Cell Culture Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  327. NUNOMURA A, Zhu X, Perry G
    Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration.
    J Alzheimers Dis. 2016;55:73-75.
    PubMed     Text format     Abstract available


    October 2016
  328. OCHOA JF, Alonso JF, Duque JE, Tobon CA, et al
    Successful Scene Encoding Induces Increased Directed Connectivity in Presymptomatic Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  329. LEE M, Guo JP, Kennedy K, McGeer EG, et al
    A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-beta Protein 42 Levels.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  330. MENDIOLA-PRECOMA J, Padilla K, Rodriguez-Cruz A, Berumen LC, et al
    Theobromine-Induced Changes in A1 Purinergic Receptor Gene Expression and Distribution in a Rat Brain Alzheimer's Disease Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  331. DE LA RUBIA ORTI JE, Castillo SS, Benlloch M, Rochina MJ, et al
    Impact of the Relationship of Stress and the Immune System in the Appearance of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  332. CUMMINGS J, Scheltens P, McKeith I, Blesa R, et al
    Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  333. CAI Q, Tammineni P
    Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  334. SERINO S, Riva G
    The Proactive Self in Space: How Egocentric and Allocentric Spatial Impairments Contribute to Anosognosia in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  335. CEBERS G, Alexander RC, Haeberlein SB, Han D, et al
    AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  336. ANDERSON M, Xu F, Ou-Yang MH, Davis J, et al
    Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  337. ZHUANG X, Chen Y, Zhuang X, Xing T, et al
    Impaired Center-Surround Suppression in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  338. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:1687-1690.
    PubMed     Text format    


  339. LEWCZUK P, Matzen A, Blennow K, Parnetti L, et al
    Cerebrospinal Fluid Abeta42/40 Corresponds Better than Abeta42 to Amyloid PET in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  340. DE LA MONTE SM, Tong M, Schiano I, Didsbury J, et al
    Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  341. CRISPOLTONI L, Stabile AM, Pistilli A, Venturelli M, et al
    Changes in Plasma beta-NGF and Its Receptors Expression on Peripheral Blood Monocytes During Alzheimer's Disease Progression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  342. TONG Z, Wang W, Luo W, Lv J, et al
    Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  343. ANDREOTTI J, Dierks T, Wahlund LO, Grieder M, et al
    Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  344. MCCLURE R, Ong H, Janve V, Barton S, et al
    Aerosol Delivery of Curcumin Reduced Amyloid-beta Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  345. NOGUCHI-SHINOHARA M, Komatsu J, Samuraki M, Matsunari I, et al
    Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  346. MARTINS IV, Rivers-Auty J, Allan SM, Lawrence CB, et al
    Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  347. LAITERA T, Paananen J, Helisalmi S, Sarajarvi T, et al
    Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-beta Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  348. DRONSE J, Fliessbach K, Bischof GN, von Reutern B, et al
    In vivo Patterns of Tau Pathology, Amyloid-beta Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  349. COSKUN P, Helguera P, Nemati Z, Bohannan RC, et al
    Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  350. SHEN Y, Xia Y, Meng S, Lim NK, et al
    SH2B1 is Involved in the Accumulation of Amyloid-beta42 in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  351. HUEY ED, Lee S, Cheran G, Grafman J, et al
    Brain Regions Involved in Arousal and Reward Processing are Associated with Apathy in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  352. ULSTEIN I, Bohmer T
    Normal Vitamin Levels and Nutritional Indices in Alzheimer's Disease Patients with Mild Cognitive Impairment or Dementia with Normal Body Mass Indexes.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  353. DEKENS DW, Naude PJ, Engelborghs S, Vermeiren Y, et al
    Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  354. DUGGER BN, Whiteside CM, Maarouf CL, Walker DG, et al
    The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:1249.
    PubMed     Text format    



  355. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:1253-1257.
    PubMed     Text format    


  356. MCGEER PL, Rogers J, McGeer EG
    Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
    J Alzheimers Dis. 2016;54:853-857.
    PubMed     Text format     Abstract available


  357. LIN F, Ren P, Lo RY, Chapman BP, et al
    Insula and Inferior Frontal Gyrus' Activities Protect Memory Performance Against Alzheimer's Disease Pathology in Old Age.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  358. VARMA VR, Watts A
    Daily Physical Activity Patterns During the Early Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  359. RIVERO-SANTANA A, Ferreira D, Perestelo-Perez L, Westman E, et al
    Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  360. AN H, Choi B, Park KW, Kim DH, et al
    The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  361. MIRANDA LF, Gomes KB, Tito PA, Silveira JN, et al
    Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  362. WANG R, Reddy PH
    Role of Glutamate and NMDA Receptors in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  363. LEGER D, Elbaz M, Dubois A, Rio S, et al
    Alzheimer's Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  364. DUCLOS H, de La Sayette V, Bonnet AL, Viard A, et al
    Social Cognition in the Frontal Variant of Alzheimer's Disease: A Case Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  365. JHA SK, Jha NK, Kumar D, Sharma R, et al
    Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  366. KEPP KP
    Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  367. CUCCARO D, De Marco EV, Cittadella R, Cavallaro S, et al
    Copy Number Variants in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  368. XIE B, Liu Z, Jiang L, Liu W, et al
    Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  369. HAFKEMEIJER A, Moller C, Dopper EG, Jiskoot LC, et al
    A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  370. SERRA L, Mancini M, Cercignani M, Di Domenico C, et al
    Network-Based Substrate of Cognitive Reserve in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  371. KITAMURA Y, Inden M, Kimoto Y, Takata K, et al
    Effects of a DJ-1-Binding Compound on Spatial Learning and Memory Impairment in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  372. ARNERIC SP, Batrla-Utermann R, Beckett L, Bittner T, et al
    Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  373. DINKINS MB, Wang G, Bieberich E
    Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  374. KIM J, Schweizer TA, Fischer CE, Munoz DG, et al
    The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  375. DARST BF, Koscik RL, Racine AM, Oh JM, et al
    Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-beta Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  376. GUO L, Tian J, Du H
    Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  377. PHILIPPENS IH, Ormel PR, Baarends G, Johansson M, et al
    Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  378. RAHA AA, Henderson JW, Stott SR, Vuono R, et al
    Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  379. BETHEA CL, Reddy AP, Christian FL
    How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  380. ARDEKANI BA, Bermudez E, Mubeen AM, Bachman AH, et al
    Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  381. RODRIGUEZ CRUZ Y, Strehaiano M, Rodriguez Obaya T, Garcia Rodriguez JC, et al
    An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  382. LEWCZUK P, Lelental N, Lachmann I, Holzer M, et al
    Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  383. ZIMETTI F, Caffarra P, Ronda N, Favari E, et al
    Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  384. DAL-PAN A, Dudonne S, Bourassa P, Bourdoulous M, et al
    Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  385. MYUNG W, Lee C, Park JH, Woo SY, et al
    Occupational Attainment as Risk Factor for Progression from Mild Cognitive Impairment to Alzheimer's Disease: A CREDOS Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  386. DOMINGUEZ-PRIETO M, Velasco A, Vega L, Tabernero A, et al
    Aberrant Co-Localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-beta Peptides: Protective Effect of Human Serum Albumin.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  387. BRUGGENJURGEN B, Andersohn F, Burkowitz J, Ezzat N, et al
    Cohort Study on Predictors of Need for Nursing Care in Alzheimer's Disease: An Analysis of Healthcare Data.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  388. SAINAGHI PP, Bellan M, Lombino F, Alciato F, et al
    Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  389. ROBILLARD JM, Feng TL
    Health Advice in a Digital World: Quality and Content of Online Information about the Prevention of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  390. TURRO-GARRIGA O, Garre-Olmo J, Rene-Ramirez R, Calvo-Perxas L, et al
    Consequences of Anosognosia on the Cost of Caregivers' Care in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  391. MUSUNURI S, Khoonsari PE, Mikus M, Wetterhall M, et al
    Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  392. TOMBINI M, Sicari M, Pellegrino G, Ursini F, et al
    Nutritional Status of Patients with Alzheimer's Disease and Their Caregivers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  393. MUELLER KD, Koscik RL, Turkstra LS, Riedeman SK, et al
    Connected Language in Late Middle-Aged Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  394. GOOSSENS J, Laton J, Van Schependom J, Gielen J, et al
    EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  395. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:847-52.
    PubMed     Text format    


  396. CESTARI JA, Fabri GM, Kalil J, Nitrini R, et al
    Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.
    J Alzheimers Dis. 2016;54:845.
    PubMed     Text format    


  397. MAGNIN E, Demonet JF, Wallon D, Dumurgier J, et al
    Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  398. RACINE AM, Clark LR, Berman SE, Koscik RL, et al
    Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  399. MUKHAMEDYAROV MA, Rizvanov AA, Yakupov EZ, Zefirov AL, et al
    Transcriptional Analysis of Blood Lymphocytes and Skin Fibroblasts, Keratinocytes, and Endothelial Cells as a Potential Biomarker for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  400. WIJESINGHE P, Shankar SK, Yasha TC, Gorrie C, et al
    Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  401. BRODY M, Liu E, Di J, Lu M, et al
    A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  402. MAZZEO S, Santangelo R, Bernasconi MP, Cecchetti G, et al
    Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  403. BENGOETXEA X, de Cerain AL, Azqueta A, Ramirez MJ, et al
    Purported Interactions of Amyloid-beta and Glucocorticoids in Cytotoxicity and Genotoxicity: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  404. FARR SA, Sandoval KE, Niehoff ML, Witt KA, et al
    Peripheral Administration of GSK-3beta Antisense Oligonucleotide Improves Learning and Memory in SAMP8 and Tg2576 Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  405. FRIED I
    Brain Stimulation in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  406. RAJMOHAN R, Reddy PH
    Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  407. YOSHINO Y, Mori T, Yoshida T, Yamazaki K, et al
    Elevated mRNA Expression and Low Methylation of SNCA in Japanese Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  408. RENARD D, Gabelle A, Hirtz C, Demattei C, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  409. LEVY B, Tsoy E, Gable S
    Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  410. ESTRADA LD, Chamorro D, Yanez MJ, Gonzalez M, et al
    Reduction of Blood Amyloid-beta Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  411. MARESOVA P, Klimova B, Novotny M, Kuca K, et al
    Alzheimer's and Parkinson's Diseases: Expected Economic Impact on Europe- A Call for a Uniform European Strategy.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  412. RAI N, Kumar R, Desai GR, Venugopalan G, et al
    Relative Alterations in Blood-Based Levels of Sestrin in Alzheimer's Disease and Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  413. WOLFSGRUBER S, Kleineidam L, Wagner M, Mosch E, et al
    Differential Risk of Incident Alzheimer's Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  414. TAHERI S, Yu J, Zhu H, Kindy MS, et al
    High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  415. SHANKLE WR, Hara J, Barrentine LW, Curole MV, et al
    CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer's Disease and Cerebrovascular Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  416. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:411-5.
    PubMed     Text format    



  417. Mark W. Bondi, PhD, Recipient of 2016 Alzheimer Award.
    J Alzheimers Dis. 2016;54:1-2.
    PubMed     Text format    


  418. SCHARRE DW, Chang SI, Nagaraja HN, Park A, et al
    Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  419. LIMA S, Gago M, Garrett C, Pereira MG, et al
    Predictors and Moderators of Quality of Life in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  420. SEPE-MONTI M, Vanacore N, Bartorelli L, Tognetti A, et al
    The Savvy Caregiver Program: A Probe Multicenter Randomized Controlled Pilot Trial in Caregivers of Patients Affected by Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  421. YU Q, Fang D, Swerdlow RH, Yu H, et al
    Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  422. CHAPLEAU M, Aldebert J, Montembeault M, Brambati SM, et al
    Atrophy in Alzheimer's Disease and Semantic Dementia: An ALE Meta-Analysis of Voxel-Based Morphometry Studies.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  423. DE BEAUMONT L, Pelleieux S, Lamarre-Theroux L, Dea D, et al
    Butyrylcholinesterase K and Apolipoprotein E-varepsilon4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  424. MAHESHWARI P, Eslick GD
    Bacterial Infection Increases the Risk of Alzheimer's Disease: An Evidence-Based Assessment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  425. VAN STEENOVEN I, Aarsland D, Weintraub D, Londos E, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.
    J Alzheimers Dis. 2016;54:287-95.
    PubMed     Text format     Abstract available


  426. GERTJE EC, Pluta J, Das S, Mancuso L, et al
    Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  427. SELIVANOVA OM, Surin AK, Marchenkov VV, Dzhus UF, et al
    The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-beta Peptide.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  428. CHEN G, Shu H, Chen G, Ward BD, et al
    Staging Alzheimer's Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  429. VIJAYAN M, Reddy PH
    Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  430. EL HAJ M, Antoine P
    Death Preparation and Boredom Reduction as Functions of Reminiscence in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  431. CALDERON-GARCIDUENAS L, Avila-Ramirez J, Calderon-Garciduenas A, Gonzalez-Heredia T, et al
    Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  432. HAKOBYAN S, Harding K, Aiyaz M, Hye A, et al
    Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  433. KANG JM, Yeon BK, Cho SJ, Suh YH, et al
    Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  434. VILLARREAL AE, Grajales S, O'Bryant SE, Edwards M, et al
    Characterization of Alzheimer's Disease and Mild Cognitive Impairment in Older Adults in Panama.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  435. SEO EH, Kim SH, Park SH, Kang SH, et al
    Topographical APOE varepsilon4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  436. HO BL, Kao YH, Chou MC, Yang YH, et al
    Cerebral White Matter Changes on Therapeutic Response to Rivastigmine in Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:351-7.
    PubMed     Text format     Abstract available


  437. WANG H, Wang Y, Hong X, Li S, et al
    Quantitative Proteomics Reveals the Mechanism of Oxygen Treatment on Lenses of Alzheimer's Disease Model Mice.
    J Alzheimers Dis. 2016;54:275-86.
    PubMed     Text format     Abstract available


  438. JAAKKIMAINEN RL, Bronskill SE, Tierney MC, Herrmann N, et al
    Identification of Physician-Diagnosed Alzheimer's Disease and Related Dementias in Population-Based Administrative Data: A Validation Study Using Family Physicians' Electronic Medical Records.
    J Alzheimers Dis. 2016;54:337-49.
    PubMed     Text format     Abstract available


  439. LIU S, Ong YT, Hilal S, Loke YM, et al
    The Association Between Retinal Neuronal Layer and Brain Structure is Disrupted in Patients with Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  440. BECKELMAN BC, Day S, Zhou X, Donohue M, et al
    Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  441. ROSENBERG PB, Lanctot KL, Herrmann N, Mintzer JE, et al
    Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2016;54:373-81.
    PubMed     Text format     Abstract available


  442. SOMERS C, Struyfs H, Goossens J, Niemantsverdriet E, et al
    A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.
    J Alzheimers Dis. 2016;54:383-95.
    PubMed     Text format     Abstract available


  443. MARTIRE S, Fuso A, Mosca L, Forte E, et al
    Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.
    J Alzheimers Dis. 2016;54:307-24.
    PubMed     Text format     Abstract available



  444. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:1653-7.
    PubMed     Text format    



  445. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:1231-5.
    PubMed     Text format    


  446. ITZHAKI RF
    Herpes and Alzheimer's Disease: Subversion in the Central Nervous System and How It Might Be Halted.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  447. AROSIO B, Casati M, Gussago C, Ferri E, et al
    Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer's Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A New/Old Potential Target.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  448. GOLDWASER EL, Acharya NK, Sarkar A, Godsey G, et al
    Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  449. GRINBERG LT, Anghinah R, Nascimento CF, Amaro E, et al
    Chronic Traumatic Encephalopathy Presenting as Alzheimer's Disease in a Retired Soccer Player.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  450. MANDECKA M, Budziszewska M, Barczak A, Peplonska B, et al
    Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  451. ULAMEK-KOZIOL M, Kocki J, Bogucka-Kocka A, Petniak A, et al
    Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  452. HULSEMANN M, Zafiu C, Kuhbach K, Luhmann N, et al
    Biofunctionalized Silica Nanoparticles: Standards in Amyloid-beta Oligomer-Based Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  453. MIDORIKAWA A, Leyton CE, Foxe D, Landin-Romero R, et al
    All Is Not Lost: Positive Behaviors in Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia with Disease Severity.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  454. DURAZZO TC, Korecka M, Trojanowski JQ, Weiner MW, et al
    Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  455. MALPAS CB, Vivash L, Genc S, Saling MM, et al
    A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  456. CHIASSERINI D, Biscetti L, Farotti L, Eusebi P, et al
    Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  457. LOZANO AM, Fosdick L, Chakravarty MM, Leoutsakos JM, et al
    A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  458. VENTURELLI M, Sollima A, Ce E, Limonta E, et al
    Effectiveness of Exercise- and Cognitive-Based Treatments on Salivary Cortisol Levels and Sundowning Syndrome Symptoms in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:1631-40.
    PubMed     Text format     Abstract available


  459. JAKOBSEN JE, Johansen MG, Schmidt M, Liu Y, et al
    Expression of the Alzheimer's Disease Mutations AbetaPP695sw and PSEN1M146I in Double-Transgenic Gottingen Minipigs.
    J Alzheimers Dis. 2016;53:1617-30.
    PubMed     Text format     Abstract available


  460. LI X, Jia S, Zhou Z, Hou C, et al
    The Gesture Imitation in Alzheimer's Disease Dementia and Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2016;53:1577-84.
    PubMed     Text format     Abstract available


  461. ROSSINI PM, Di Iorio R, Granata G, Miraglia F, et al
    From Mild Cognitive Impairment to Alzheimer's Disease: A New Perspective in the "Land" of Human Brain Reactivity and Connectivity.
    J Alzheimers Dis. 2016;53:1389-93.
    PubMed     Text format     Abstract available


  462. ETTCHETO M, Petrov D, Pedros I, Alva N, et al
    Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
    J Alzheimers Dis. 2016;54:233-51.
    PubMed     Text format     Abstract available



  463. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:747-51.
    PubMed     Text format    


  464. JAHNG GH, Oh J, Lee DW, Kim HG, et al
    Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:745.
    PubMed     Text format    


  465. PENNINKILAMPI R, Brothers HM, Eslick GD
    Pharmacological Agents Targeting gamma-Secretase Increase Risk of Cancer and Cognitive Decline in Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  466. DE VOS A, Struyfs H, Jacobs D, Fransen E, et al
    The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  467. BANGEN KJ, Himali JJ, Beiser AS, Nation DA, et al
    Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  468. KANG S, Jeong H, Baek JH, Lee SJ, et al
    PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  469. ADIELE RC, Adiele CA
    Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  470. SALEM H, Rocha NP, Colpo GD, Teixeira AL, et al
    Moving from the Dish to the Clinical Practice: A Decade of Lessons and Perspectives from the Pre-Clinical and Clinical Stem Cell Studies for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  471. DAVID R, Manera V, Fabre R, Pradier C, et al
    Evolution of the Rate of Antidepressant Prescriptions in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  472. IDRIZBEGOVIC E, Hederstierna C, Rosenhall U
    Mismatch Negativity and Ear Laterality in Alzheimer's Disease and in Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  473. ANDERSSON CH, Hansson O, Minthon L, Andreasen N, et al
    A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  474. AMBROSE CT
    The Role of Capillaries in the Lesser Ailments of Old Age and in Alzheimer's Disease and Vascular Dementia: The Potential of Pro-Therapeutic Angiogenesis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  475. GROSSI E, Stoccoro A, Tannorella P, Migliore L, et al
    Artificial Neural Networks Link One-Carbon Metabolism to Gene-Promoter Methylation in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  476. BRONNICK K, Breitve MH, Rongve A, Aarsland D, et al
    Neurocognitive Deficits Distinguishing Mild Dementia with Lewy Bodies from Mild Alzheimer's Disease are Associated with Parkinsonism.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  477. ZIMMERER VC, Wibrow M, Varley RA
    Formulaic Language in People with Probable Alzheimer's Disease: A Frequency-Based Approach.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  478. PIETTO M, Parra MA, Trujillo N, Flores F, et al
    Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  479. BIELLA G, Fusco F, Nardo E, Bernocchi O, et al
    Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-beta Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  480. DENG Y, Wei J, Cheng J, Zhong P, et al
    Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  481. ALLEN HB
    Alzheimer's Disease: Assessing the Role of Spirochetes, Biofilms, the Immune System, and Amyloid-beta with Regard to Potential Treatment and Prevention.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  482. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;53:363-6.
    PubMed     Text format    


  483. MAKOVAC E, Serra L, Spano B, Giulietti G, et al
    Different Patterns of Correlation between Grey and White Matter Integrity Account for Behavioral and Psychological Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:591-604.
    PubMed     Text format     Abstract available


  484. PRETORIUS E, Bester J, Kell DB
    A Bacterial Component to Alzheimer's-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  485. MOHSENI HK, Cowan D, Chettle DR, Milic AP, et al
    A Pilot Study Measuring Aluminum in Bone in Alzheimer's Disease and control Subjects Using in vivo Neutron Activation Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  486. WANG J, Ye F, Cheng X, Zhang X, et al
    The Effects of LW-AFC on Intestinal Microbiome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  487. HAWKINS KM, Sergio LE
    Adults at Increased Alzheimer's Disease Risk Display Cognitive-Motor Integration Impairment Associated with Changes in Resting-State Functional Connectivity: A Preliminary Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  488. LIN CY, Cheng YS, Liao TY, Lin C, et al
    Intranasal Administration of a Polyethylenimine-Conjugated Scavenger Peptide Reduces Amyloid-beta Accumulation in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  489. CHOURAKI V, Reitz C, Maury F, Bis JC, et al
    Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  490. VERMEIREN Y, Janssens J, Aerts T, Martin JJ, et al
    Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  491. OLSEN I, Singhrao SK
    Inflammasome Involvement in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  492. ZHAI Y, Yamashita T, Nakano Y, Sun Z, et al
    Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  493. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;52:1515-9.
    PubMed     Text format    


    May 2016
  494. HOFRICHTER J, Krohn M, Schumacher T, Lange C, et al
    Sideritis spp. Extracts Enhance Memory and Learning in Alzheimer's beta-Amyloidosis Mouse Models and Aged C57Bl/6 Mice.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  495. ALLUE JA, Sarasa L, Izco M, Perez-Grijalba V, et al
    Outstanding Phenotypic Differences in the Profile of Amyloid-beta between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  496. CAMPANARI ML, Navarrete F, Ginsberg SD, Manzanares J, et al
    Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  497. DERMODY N, Wong S, Ahmed R, Piguet O, et al
    Uncovering the Neural Bases of Cognitive and Affective Empathy Deficits in Alzheimer's Disease and the Behavioral-Variant of Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  498. ARENDASH GW
    Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  499. EUGENIN J, Vecchiola A, Murgas P, Arroyo P, et al
    Expression Pattern of Scavenger Receptors and Amyloid-beta Phagocytosis of Astrocytes and Microglia in Culture are Modified by Acidosis: Implications for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  500. OBOSHI Y, Kikuchi M, Terada T, Yoshikawa E, et al
    Alterations in Phase-Related Prefrontal Activation During Cognitive Tasks and Nicotinic alpha4beta2 Receptor Availability in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  501. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;52:1151-1155.
    PubMed     Text format    


  502. DEL VALLE E, Navarro A, Martinez-Pinilla E, Torices S, et al
    Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  503. HIRD MA, Egeto P, Fischer CE, Naglie G, et al
    A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  504. TAIPA R, Sousa AL, Melo Pires M, Sousa N, et al
    Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer's Disease Clinical Phenotypes? A Clinico-Pathological Perspective.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  505. LANDEL V, Annweiler C, Millet P, Morello M, et al
    Vitamin D, Cognition, and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  506. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;52:775-779.
    PubMed     Text format    


  507. DI MECO A, Pratico D
    MicroRNAs as Therapeutic Targets for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  508. TAJEDDINN W, Persson T, Calvo-Garrido J, Seed Ahmed M, et al
    Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  509. SZALARDY L, Zadori D, Klivenyi P, Vecsei L, et al
    The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  510. KASZA A, Hunya A, Frank Z, Fulop F, et al
    Dihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  511. FARNSWORTH B, Peuckert C, Zimmermann B, Jazin E, et al
    Gene Expression of Quaking in Sporadic Alzheimer's Disease Patients is Both Upregulated and Related to Expression Levels of Genes Involved in Amyloid Plaque and Neurofibrillary Tangle Formation.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  512. WANG MJ, Yi S, Han JY, Park SY, et al
    Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  513. HAPPICH M, Kirson NY, Desai U, King S, et al
    Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  514. MALISZEWSKA-CYNA E, Xhima K, Aubert I
    A Comparative Study Evaluating the Impact of Physical Exercise on Disease Progression in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  515. VERMA N, Ly H, Liu M, Chen J, et al
    Intraneuronal Amylin Deposition Peroxidative Membrane Injury and Increased IL-1beta Synthesis in Brains of Alzheimer's Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  516. BOLIVAR JC, Saladie DG
    Redefining Amnestic Mild Cognitive Impairment as an Early Form of Alzheimer's Disease Based on Assessment of Memory Systems.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  517. TAJEDDINN W, Fereshtehnejad SM, Seed Ahmed M, Yoshitake T, et al
    Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  518. RUSSU A, Samtani MN, Xu S, Adedokun OJ, et al
    Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    April 2016

  519. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;52:385-9.
    PubMed     Text format    


  520. MARIN-MUNOZ J, Noguera-Perea MF, Gomez-Tortosa E, Lopez-Motos D, et al
    Novel Mutation (Gly212Val) in the PS2 Gene Associated with Early-Onset Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  521. EL GAAMOUCH F, Jing P, Xia J, Cai D, et al
    Alzheimer's Disease Risk Genes and Lipid Regulators.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  522. UEKAWA K, Hasegawa Y, Senju S, Nakagata N, et al
    Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  523. YE BS, Lee Y, Kwak K, Park YH, et al
    Posterior Ventricular Enlargement to Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  524. TROJANO L, Gainotti G
    Drawing Disorders in Alzheimer's Disease and Other Forms of Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  525. CESTARI JA, Fabri GM, Kalil J, Nitrini R, et al
    Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  526. HAN P, Shi J
    A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  527. MULLER S, Mychajliw C, Reichert C, Melcher T, et al
    Autobiographical Memory Performance in Alzheimer's Disease Depends on Retrieval Frequency.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  528. CRETIN B, Sellal F, Philippi N, Bousiges O, et al
    Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  529. CLARELLI F, Mascia E, Santangelo R, Mazzeo S, et al
    CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  530. INGBER AP, Hassenstab J, Fagan AM, Benzinger TL, et al
    Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  531. HENSLEY K, Kursula P
    Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  532. BERGER M, Nadler JW, Friedman A, McDonagh DL, et al
    The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  533. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:1291-5.
    PubMed     Text format    


  534. OTA K, Oishi N, Ito K, Fukuyama H, et al
    Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  535. ZHAI Y, Yamashita T, Nakano Y, Sun Z, et al
    Disruption of White Matter Integrity by Chronic Cerebral Hypoperfusion in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  536. HOSCHEIDT SM, Starks EJ, Oh JM, Zetterberg H, et al
    Insulin Resistance is Associated with Increased Alzheimer's Disease Pathology and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  537. CONDE-SALA JL, Turro-Garriga O, Portellano-Ortiz C, Vinas-Diez V, et al
    Self-Perceived Quality of Life Among Patients with Alzheimer's Disease: Two Longitudinal Models of Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  538. WANG W, Lu L, Wu QQ, Jia JP, et al
    Brain Amyloid-beta Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  539. REGO A, Viana SD, Ribeiro CA, Rodrigues-Santos P, et al
    Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  540. XING Y, Tang Y, Zhao L, Wang Q, et al
    Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  541. NILSSON ED, Melander O, Elmstahl S, Lethagen E, et al
    Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  542. TEIPEL S, Grothe MJ
    Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  543. HENNEGES C, Reed C, Chen YF, Dell'Agnello G, et al
    Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  544. WARAGAI M, Adame A, Trinh I, Sekiyama K, et al
    Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  545. ZHAN Y, Ma J, Alexander-Bloch AF, Xu K, et al
    Longitudinal Study of Impaired Intra- and Inter-Network Brain Connectivity in Subjects at High Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  546. BEHESHTI I, Olya HG, Demirel H
    Risk Assessment of Alzheimer's Disease using the Information Diffusion Model from Structural Magnetic Resonance Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  547. HUANG HC, Zheng BW, Guo Y, Zhao J, et al
    Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  548. JAYNE T, Newman M, Verdile G, Sutherland G, et al
    Evidence for and Against a Pathogenic Role of Reduced gamma-Secretase Activity in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  549. ZHAI Y, Yin S, Zhang D
    Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  550. EBRAHIMIE E, Moussavi-Nik SH, Newman M, Van Der Hoek M, et al
    The Zebrafish Equivalent of Alzheimer's Disease-Associated PRESENILIN Isoform PS2V Regulates Inflammatory and Other Responses to Hypoxic Stress.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  551. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:929-934.
    PubMed     Text format    


  552. PIAZZA F, Winblad B
    Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  553. VIDAL JS, Hanon O, Funalot B, Brunel N, et al
    Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  554. KUSTER OC, Kosel J, Spohn S, Schurig N, et al
    Cognitive Reserve in Alzheimer's Dementia: Diagnostic Accuracy of a Testing-the-Limits Paradigm.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  555. HEFFERNAN M, Mather KA, Xu J, Assareh AA, et al
    Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study.
    J Alzheimers Dis. 2016;52:529-38.
    PubMed     Text format     Abstract available


  556. CUCHILLO-IBANEZ I, Balmaceda V, Mata-Balaguer T, Lopez-Font I, et al
    Reelin in Alzheimer's Disease, Increased Levels but Impaired Signaling: When More is Less.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  557. HIRNI DI, Kivisaari SL, Krumm S, Monsch AU, et al
    Neuropsychological Markers of Medial Perirhinal and Entorhinal Cortex Functioning are Impaired Twelve Years Preceding Diagnosis of Alzheimer's Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  558. CLEMENTS-CORTES A, Ahonen H, Evans M, Freedman M, et al
    Short-Term Effects of Rhythmic Sensory Stimulation in Alzheimer's Disease: An Exploratory Pilot Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  559. YANG C, Huang X, Huang X, Mai H, et al
    Aquaporin-4 and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  560. HU Q, Teng W, Li J, Hao F, et al
    Homocysteine and Alzheimer's Disease: Evidence for a Causal Link from Mendelian Randomization.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  561. ONTIVEROS-TORRES MA, Labra-Barrios ML, Diaz-Cintra S, Aguilar-Vazquez AR, et al
    Fibrillar Amyloid-beta Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3xTg-AD Transgenic Mouse.
    J Alzheimers Dis. 2016;52:243-69.
    PubMed     Text format     Abstract available


  562. MIN JY, Min KB
    The Folate-Vitamin B12 Interaction, Low Hemoglobin, and the Mortality Risk from Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  563. ZHAO QF, Wan Y, Wang HF, Sun FR, et al
    ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-beta Pathology.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  564. EL HAJ M, Kapogiannis D, Antoine P
    Phenomenological Reliving and Visual Imagery During Autobiographical Recall in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  565. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:631-5.
    PubMed     Text format    


  566. NHO K, Saykin AJ, Nelson PT
    Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  567. SCHUTT T, Helboe L, Ostergaard Pedersen L, Waldemar G, et al
    Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  568. WANG HF, Wan Y, Hao XK, Cao L, et al
    Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  569. HOMMA A, Atarashi H, Kubota N, Nakai K, et al
    Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  570. ITZHAKI RF, Lathe R, Balin BJ, Ball MJ, et al
    Microbes and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format    


  571. YE Q, Bai F, Zhang Z
    Shared Genetic Risk Factors for Late-Life Depression and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  572. SPILMAN PR, Corset V, Gorostiza O, Poksay KS, et al
    Netrin-1 Interrupts Amyloid-beta Amplification, Increases sAbetaPPalpha in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  573. LINGLER JH, Butters MA, Gentry AL, Hu L, et al
    Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.
    J Alzheimers Dis. 2016;52:17-24.
    PubMed     Text format     Abstract available


  574. FERNANDEZ-BLAZQUEZ MA, Avila-Villanueva M, Maestu F, Medina M, et al
    Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.
    J Alzheimers Dis. 2016;52:271-81.
    PubMed     Text format     Abstract available


  575. JEFFERSON AL, Gifford KA, Acosta LM, Bell SP, et al
    The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview.
    J Alzheimers Dis. 2016;52:539-59.
    PubMed     Text format     Abstract available


  576. SHANG J, Yamashita T, Zhai Y, Nakano Y, et al
    Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  577. LOPEZ ME, Turrero A, Cuesta P, Lopez-Sanz D, et al
    Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  578. JAHNG GH, Oh J, Lee DW, Kim HG, et al
    Glutamine and Glutamate Complex, as Measured by Functional Magnetic Resonance Spectroscopy, Alters During Face-Name Association Task in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  579. FEMMINELLA GD, Ninan S, Atkinson R, Fan Z, et al
    Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
    J Alzheimers Dis. 2016;51:1275-89.
    PubMed     Text format     Abstract available


  580. YOON B, Yang DW, Hong YJ, Choi SH, et al
    Differences in Depressive Patterns According to Disease Severityin Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  581. TIIHONEN M, Taipale H, Tanskanen A, Tiihonen J, et al
    Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  582. PASQUIER F, Sadowsky C, Holstein A, Leterme GL, et al
    Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


    February 2016
  583. REMINGTON R, Bechtel C, Larsen D, Samar A, et al
    Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  584. FLORIAN H, Meier A, Gauthier S, Lipschitz S, et al
    Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  585. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;51:327-331.
    PubMed     Text format    


  586. PECK K, Girard TA, Russo F, Fiocco AJ, et al
    Music and Memory in Alzheimer's Disease and The Potential Underlying Mechanisms.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  587. SCHILLING MA
    Unraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  588. SANDERS C, Behrens S, Schwartz S, Wengreen H, et al
    Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1.
    J Alzheimers Dis. 2016;52:33-42.
    PubMed     Text format     Abstract available


  589. TAN CC, Wan Y, Tan MS, Zhang W, et al
    Association of Frontotemporal Dementia GWAS Loci with Late-Onset Alzheimer's Disease in a Northern Han Chinese Population.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  590. LAVALLEE MM, Gandini D, Rouleau I, Vallet GT, et al
    A Qualitative Impairment in Face Perception in Alzheimer's Disease: Evidence from a Reduced Face Inversion Effect.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  591. GOMAR JJ, Conejero-Goldberg C, Davies P, Goldberg TE, et al
    Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  592. MASOUD AM, Bihaqi SW, Machan JT, Zawia NH, et al
    Early-Life Exposure to Lead (Pb) Alters the Expression of microRNA that Target Proteins Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  593. WONG S, Bertoux M, Savage G, Hodges JR, et al
    Comparison of Prefrontal Atrophy and Episodic Memory Performance in Dysexecutive Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  594. MONTESANTO A, Crocco P, Anfossi M, Smirne N, et al
    The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-varepsilon4 Carriers.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  595. GUILLOT F, Kemppainen S, Lavasseur G, Miettinen PO, et al
    Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AbetaPP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  596. ONGALI B, Nicolakakis N, Tong XK, Aboulkassim T, et al
    Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  597. BOUSIGES O, Cretin B, Lavaux T, Philippi N, et al
    Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Abeta42, and Abeta40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  598. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:1257-61.
    PubMed     Text format    


  599. SAKAI K, Senda T, Hata R, Kuroda M, et al
    Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  600. BARTHELEMY NR, Gabelle A, Hirtz C, Fenaille F, et al
    Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  601. CHAI YL, Yeo HK, Wang J, Hilal S, et al
    Apolipoprotein varepsilon4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  602. SANCHEZ-VALLE R, Monte GC, Sala-Llonch R, Bosch B, et al
    White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  603. SUPPA P, Hampel H, Kepp T, Lange C, et al
    Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  604. SINGHRAO SK, Harding A, Chukkapalli S, Olsen I, et al
    Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  605. PLUTA R, Kocki J, Ulamek-Koziol M, Petniak A, et al
    Discrepancy in Expression of beta-Secretase and Amyloid-beta Protein Precursor in Alzheimer-Related Genes in the Rat Medial Temporal Lobe Cortex Following Transient Global Brain Ischemia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  606. CHAU SA, Chung J, Herrmann N, Eizenman M, et al
    Apathy and Attentional Biases in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  607. LYOO CH, Cho H, Choi JY, Hwang MS, et al
    Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  608. LOU G, Zhang Q, Xiao F, Xiang Q, et al
    Intranasal TAT-haFGF Improves Cognition and Amyloid-beta Pathology in an AbetaPP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  609. SOUTHAM KA, Vincent AJ, Small DH
    Do Microglia Default on Network Maintenance in Alzheimer's Disease?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  610. DINGOVA D, Fazekas T, Okuliarova P, Strbova J, et al
    Low Plasma Cholinesterase Activities are associated with Deficits in Spatial Orientation, Reduced Ability to Perform Basic Activities of Daily Living, and Low Body Mass Index in Patients with Progressed Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  611. MOON Y, Han SH, Moon WJ
    Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  612. BONET-COSTA V, Herranz-Perez V, Blanco-Gandia M, Mas-Bargues C, et al
    Clearing Amyloid-beta through PPARgamma/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  613. GODEFROY O, Bakchine S, Verny M, Delabrousse-Mayoux JP, et al
    Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  614. FANG D, Zhang Z, Li H, Yu Q, et al
    Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer's disease Mouse Brain.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  615. HESSMANN P, Seeberg G, Reese JP, Dams J, et al
    Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  616. SCHUBERT S, Leyton CE, Hodges JR, Piguet O, et al
    Longitudinal Memory Profiles in Behavioral-Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  617. GRANGER MW, Franko B, Taylor MW, Messier C, et al
    A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  618. ALLISON SL, Fagan AM, Morris JC, Head D, et al
    Spatial Navigation in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  619. CHEN HY, Panegyres PK
    The Role of Ethnicity in Alzheimer's Disease: Findings From The C-PATH Online Data Repository.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  620. WHITE MT, Shaw LM, Xie SX
    Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  621. SERRA L, Cercignani M, Mastropasqua C, Torso M, et al
    Longitudinal Changes in Functional Brain Connectivity Predicts Conversionto Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  622. ASO E, Andres-Benito P, Carmona M, Maldonado R, et al
    Cannabinoid Receptor 2 Participates in Amyloid-beta Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  623. D'ONOFRIO G, Panza F, Sancarlo D, Paris FF, et al
    Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  624. LOUWERSHEIMER E, Keulen MA, Steenwijk MD, Wattjes MP, et al
    Heterogeneous Language Profiles in Patients with Primary Progressive Aphasiadue to Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  625. LI WX, Dai SX, Liu JQ, Wang Q, et al
    Integrated Analysis of Alzheimer's Disease and Schizophrenia Dataset Revealed Different Expression Pattern in Learningand Memory.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  626. WRUCK W, Schroter F, Adjaye J
    Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsiesand iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Revealsan Association with FOXA1 and FOXA2 Gene Regulatory Networks.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  627. KIDA J, Nemoto K, Ikejima C, Bun S, et al
    Impact of Depressive Symptomson Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  628. LACALLE-AURIOLES M, Javier Navas-Sanchez F, Aleman-Gomez Y, Olazaran J, et al
    The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  629. DUGGER BN, Whiteside CM, Maarouf CL, Walker DG, et al
    The Presence of Select Tau Speciesin Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  630. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:907-911.
    PubMed     Text format    


    January 2016
  631. BOCCHETTA M, Mega A, Bernardi L, Di Maria E, et al
    Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  632. EUSTACHE P, Nemmi F, Saint-Aubert L, Pariente J, et al
    Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  633. TONG M, Deochand C, Didsbury J, de la Monte SM, et al
    T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  634. MELAH KE, Lu SY, Hoscheidt SM, Alexander AL, et al
    Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  635. LANGLOIS R, Joubert S, Benoit S, Dostie V, et al
    Memory for Public Events in Mild Cognitive Impairment and Alzheimer's Disease:The Importance of Rehearsal.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  636. ROBILLARD JM
    The Online Environment: A Key Variable in the Ethical Response to Complementary and Alternative Medicine for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  637. DODICH A, Cerami C, Crespi C, Canessa N, et al
    Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  638. RACINE E, Forlini C, Aspler J, Chandler J, et al
    Complementary and Alternative Medicine in the Context of Earlier Diagnoses of Alzheimer's Disease: Opening the Conversation to Prepare Ethical Responses.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  639. TURRO-GARRIGA O, Garre-Olmo J, Calvo-Perxas L, Rene-Ramirez R, et al
    Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  640. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:617-21.
    PubMed     Text format    


  641. MANOUSOPOULOU A, Saito S, Yamamoto Y, Al-Daghri NM, et al
    Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  642. SMITH R, Wibom M, Olsson T, Hagerstrom D, et al
    Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  643. NAGATA T, Shinagawa S, Nakajima S, Plitman E, et al
    Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  644. WANG HF, Tan L, Cao L, Zhu XC, et al
    Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  645. PASQUINI L, Scherr M, Tahmasian M, Myers NE, et al
    Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  646. GALLUCCI M, Spagnolo P, Arico M, Grossi E, et al
    Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  647. RODRIGUEZ-PERDIGON M, Solas M, Javier Ramirez M
    JNK: A Putative Link Between Insulin Signaling and VGLUT1 in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  648. ZHANG Y, Wang S, Phillips P, Yang J, et al
    Three-Dimensional Eigenbrain for the Detection of Subjects and Brain Regions Related with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  649. MORIN JP, Ceron-Solano G, Velazquez-Campos G, Pacheco-Lopez G, et al
    Spatial Memory Impairment is Associated with Intraneural Amyloid-beta Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  650. NUNEZ K, Kay J, Krotow A, Tong M, et al
    Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  651. MANSO Y, Comes G, Lopez-Ramos JC, Belfiore M, et al
    Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  652. NIEMANTSVERDRIET E, Goossens J, Struyfs H, Martin JJ, et al
    Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  653. WANG J, Tan L, Yu JT
    Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  654. BABIC LEKO M, Borovecki F, Dejanovic N, Hof PR, et al
    Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  655. SIOTTO M, Simonelli I, Pasqualetti P, Mariani S, et al
    Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  656. BOCCARDI V, Ruggiero C, Patriti A, Marano L, et al
    Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  657. WANG HL, Wang YY, Liu XG, Kuo SH, et al
    Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  658. FERNANDEZ G, Manes F, Politi LE, Orozco D, et al
    Patients with Mild Alzheimer's Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  659. QIU H, Zhong R, Liu H, Zhang F, et al
    Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AbetaPPswe/PS1DeltaE9 Mice.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  660. MAES A, Anthonissen R, Wambacq S, Simons K, et al
    The Cytome Assay as a Tool to Investigate the Possible Association Between Exposure to Extremely Low Frequency Magnetic Fields and an Increased Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  661. KIM HJ, Cha J, Lee JM, Shin JS, et al
    Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  662. KOCH G, Di Lorenzo F, Del Olmo MF, Bonni S, et al
    Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  663. ROHER AE, Maarouf CL, Kokjohn TA
    Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  664. VIJAYARAGHAVAN S, Darreh-Shori T, Rongve A, Berge G, et al
    Association of Butyrylcholinesterase-K Allele and Apolipoprotein E varepsilon4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  665. HUANG F, Shang Y, Luo Y, Wu P, et al
    Lower Prevalence of Alzheimer's Disease among Tibetans: Association with Religious and Genetic Factors.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  666. RENARD D, Wacongne A, Ayrignac X, Charif M, et al
    Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  667. DZIEDZIC T, Pera J, Klimkowicz-Mrowiec A, Mroczko B, et al
    Biochemical and Radiological Markers of Alzheimer's Disease Progression.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available


  668. IBARRIA M, Alegret M, Valero S, Morera A, et al
    Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2016.
    PubMed     Text format     Abstract available



  669. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2016;50:297-300.
    PubMed     Text format    


  670. MOHSENI HK, Chettle DR
    A History of In Vivo Neutron Activation Analysis in Measurement of Aluminum in Human Subjects.
    J Alzheimers Dis. 2016;50:913-26.
    PubMed     Text format     Abstract available


  671. KENNEDY RE, Cutter GR, Wang G, Schneider LS, et al
    Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.
    J Alzheimers Dis. 2016;50:1205-15.
    PubMed     Text format     Abstract available


  672. LEINONEN H, Lipponen A, Gurevicius K, Tanila H, et al
    Normal Amplitude of Electroretinography and Visual Evoked Potential Responses in AbetaPP/PS1 Mice.
    J Alzheimers Dis. 2016;51:21-6.
    PubMed     Text format     Abstract available


  673. GRAMUNT N, Sanchez-Benavides G, Buschke H, Lipton RB, et al
    Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity.
    J Alzheimers Dis. 2016;50:999-1010.
    PubMed     Text format     Abstract available


  674. KUMFOR F, Teo D, Miller L, Lah S, et al
    Examining the Relationship Between Autobiographical Memory Impairment and Carer Burden in Dementia Syndromes.
    J Alzheimers Dis. 2016;51:237-48.
    PubMed     Text format     Abstract available


  675. ANDRIUTA D, Moullart V, Schraen S, Devendeville A, et al
    What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?
    J Alzheimers Dis. 2016;51:793-800.
    PubMed     Text format     Abstract available


  676. GRANGEON L, Paquet C, Bombois S, Quillard-Muraine M, et al
    Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
    J Alzheimers Dis. 2016;51:905-13.
    PubMed     Text format     Abstract available


  677. SIERKSMA AS, de Nijs L, Hoogland G, Vanmierlo T, et al
    Fluoxetine Treatment Induces Seizure Behavior and Premature Death in APPswe/PS1dE9 Mice.
    J Alzheimers Dis. 2016;51:677-82.
    PubMed     Text format     Abstract available


  678. KRISHNA K, Behnisch T, Sajikumar S
    Inhibition of Histone Deacetylase 3 Restores Amyloid-beta Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons.
    J Alzheimers Dis. 2016;51:783-91.
    PubMed     Text format     Abstract available


  679. RAMANAN S, Flanagan E, Leyton CE, Villemagne VL, et al
    Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.
    J Alzheimers Dis. 2016;51:367-76.
    PubMed     Text format     Abstract available


  680. SON SM, Shin HJ, Byun J, Kook SY, et al
    Metformin Facilitates Amyloid-beta Generation by beta- and gamma-Secretases via Autophagy Activation.
    J Alzheimers Dis. 2016;51:1197-208.
    PubMed     Text format     Abstract available


  681. XU L, Wu X, Li R, Chen K, et al
    Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    J Alzheimers Dis. 2016;51:1045-56.
    PubMed     Text format     Abstract available


  682. MIGLIACCIO R, Gallea C, Kas A, Perlbarg V, et al
    Functional Connectivity of Ventral and Dorsal Visual Streams in Posterior Cortical Atrophy.
    J Alzheimers Dis. 2016;51:1119-30.
    PubMed     Text format     Abstract available


  683. TRAMUTOLA A, Pupo G, Di Domenico F, Barone E, et al
    Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.
    J Alzheimers Dis. 2016;52:359-71.
    PubMed     Text format     Abstract available


  684. RAJI CA, Merrill DA, Eyre H, Mallam S, et al
    Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.
    J Alzheimers Dis. 2016;52:719-29.
    PubMed     Text format     Abstract available


    December 2015

  685. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:1193-6.
    PubMed     Text format    



  686. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:889-92.
    PubMed     Text format    


  687. LEWCZUK P, Kornhuber J, Toledo JB, Trojanowski JQ, et al
    Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects.
    J Alzheimers Dis. 2015;49:887.
    PubMed     Text format    


  688. BENNETT J, Burns J, Welch P, Bothwell R, et al
    Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  689. DERMODY N, Hornberger M, Piguet O, Hodges JR, et al
    Prospective Memory Impairments in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia: Clinical and Neural Correlates.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  690. HOFFMANN K, Sobol NA, Frederiksen KS, Beyer N, et al
    Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  691. YAMASHITA S, Kiko T, Fujiwara H, Hashimoto M, et al
    Alterations in the Levels of Amyloid-beta, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-beta and These Lipids.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  692. CHAKRABARTI M, McDonald AJ, Will Reed J, Moss MA, et al
    Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  693. WANG S, Zhang Y, Liu G, Phillips P, et al
    Detection of Alzheimer's Disease by Three-Dimensional Displacement Field Estimation in Structural Magnetic Resonance Imaging.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  694. GARDENER SL, Rainey-Smith SR, Martins RN
    Diet and Inflammation in Alzheimer's Disease and Related Chronic Diseases: A Review.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  695. EZRA A, Rabinovich-Nikitin I, Rabinovich-Toidman P, Solomon B, et al
    Multifunctional Effect of Human Serum Albumin Reduces Alzheimer's Disease Related Pathologies in the 3xTg Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  696. BARTOLOTTI N, Segura L, Lazarov O
    Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer's Disease Mice.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    November 2015
  697. MALISHKEVICH A, Marshall GA, Schultz AP, Sperling RA, et al
    Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  698. WEISSMANN R, Huttenrauch M, Kacprowski T, Bouter Y, et al
    Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  699. STOCKBURGER C, Miano D, Baeumlisberger M, Pallas T, et al
    A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  700. CHANG YL, Yen YS, Chen TF, Yan SH, et al
    Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  701. QUINTANA-HERNANDEZ DJ, Miro-Barrachina MT, Ibanez-Fernandez IJ, Pino AS, et al
    Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  702. FISCHER CE, Qian W, Schweizer TA, Millikin CP, et al
    Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  703. STEENLAND K, Goldstein FC, Levey A, Wharton W, et al
    A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  704. GAO L, Cui Z, Shen L, Ji HF, et al
    Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  705. AVONDINO E, Antoine P
    Heterogeneity of Cognitive Anosognosia and its Variation with the Severity of Dementia in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  706. MARRA C, Gainotti G, Fadda L, Perri R, et al
    Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  707. SANTOS CY, Lim YY, Wu WC, Machan JT, et al
    Resting-State Cardiac Workload is Related to Both Increased Neocortical Aggregation of Amyloid-beta and Relative Impairments in Spatial Working Memory in Pre-Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  708. GABELLE A, Gutierrez LA, Dartigues JF, Ritchie K, et al
    Palmomental Reflex a Relevant Sign in Early Alzheimer's Disease Diagnosis?
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  709. NOVAK G, Fox N, Clegg S, Nielsen C, et al
    Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  710. LIU J, Zhang X, Yu C, Duan Y, et al
    Impaired Parahippocampus Connectivity in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  711. DUKART J, Sambataro F, Bertolino A
    Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  712. SATTLECKER M, Khondoker M, Proitsi P, Williams S, et al
    Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  713. TOSTO G, Monsell SE, Hawes SE, Giuseppe B, et al
    Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  714. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:583-7.
    PubMed     Text format    


  715. BERTOUX M, de Souza Lc LC, O'Callaghan C, Greve A, et al
    Social Cognition Deficits: The Key to Discriminate Behavioral Variant Frontotemporal Dementia from Alzheimer's Disease Regardless of Amnesia?
    J Alzheimers Dis. 2015;49:1065-74.
    PubMed     Text format     Abstract available


  716. RHODIUS-MEESTER HF, Koikkalainen J, Mattila J, Teunissen CE, et al
    Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  717. LANGE C, Suppa P, Frings L, Brenner W, et al
    Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  718. STOGMANN E, Moser D, Klug S, Gleiss A, et al
    Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  719. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;49:267-70.
    PubMed     Text format    


    October 2015
  720. ROSENBERGER AF, Hilhorst R, Coart E, Garcia Barrado L, et al
    Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  721. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:1129-32.
    PubMed     Text format    


  722. DIAZ M, Fabelo N, Casanas-Sanchez V, Marin R, et al
    Hippocampal Lipid Homeostasis in APP/PS1 Mice is Modulated by a Complex Interplay Between Dietary DHA and Estrogens: Relevance for Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  723. JOHNEN A, Frommeyer J, Modes F, Wiendl H, et al
    Dementia Apraxia Test (DATE): A Brief Tool to Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Dementia based on Apraxia Profiles.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  724. BERGE G, Lauridsen C, Sando SB, Holder D, et al
    Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  725. WU HZ, Ong KL, Seeher K, J Armstrong N, et al
    Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  726. MADHAVAN A, Schwarz CG, Duffy JR, Strand EA, et al
    Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  727. DUBOIS B, Padovani A, Scheltens P, Rossi A, et al
    Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  728. SAARELAINEN L, Taipale H, Koponen M, Tanskanen A, et al
    The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  729. FA M, Zhang H, Staniszewski A, Saeed F, et al
    Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  730. BANERJEE P, Sahoo A, Anand S, Bir A, et al
    The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-beta Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  731. PINNOCK EC, Jovanovic K, Pinto MG, Ferreira E, et al
    LRP/LR Antibody Mediated Rescuing of Amyloid-beta-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  732. KOPPARA A, Wolfsgruber S, Kleineidam L, Schmidtke K, et al
    The Latent Dementia Phenotype delta is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  733. YE BS, Jang EY, Kim SY, Kim EJ, et al
    Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  734. FRASER KC, Meltzer JA, Rudzicz F
    Linguistic Features Identify Alzheimer's Disease in Narrative Speech.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  735. VOYLE N, Keohane A, Newhouse S, Lunnon K, et al
    A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  736. SHAH DJ, Rohlfing F, Anand S, Johnson WE, et al
    Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  737. GARCIA BARRADO L, Coart E, Vanderstichele HM, Burzykowski T, et al
    Transferring Cut-off Values between Assays for Cerebrospinal Fluid Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  738. PAN Y, Terpstra E, Wang Y, Qiao F, et al
    Dysregulation and Diagnostic Potential of microRNA in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  739. MINH DO T, Dodacki A, Alata W, Calon F, et al
    Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-beta Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  740. JOUSSAIN P, Bessy M, Fournel A, Ferdenzi C, et al
    Altered Affective Evaluations of Smells in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  741. LEVAULT KR, Tischkau SA, Brewer GJ
    Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  742. ARAB L, Sabbagh MN
    Are Certain Lifestyle Habits Associated with Lower Alzheimer's Disease Risk?
    J Alzheimers Dis. 2015;48:877.
    PubMed     Text format    



  743. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:871-4.
    PubMed     Text format    


  744. GUO Z, Liu X, Jia X, Hou H, et al
    Regional Coherence Changes in Alzheimer's Disease Patients with Depressive Symptoms: A Resting-State Functional MRI Study.
    J Alzheimers Dis. 2015;48:603-11.
    PubMed     Text format     Abstract available


    September 2015
  745. PASTOR P, Moreno F, Clarimon J, Ruiz A, et al
    MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEvarepsilon4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  746. COUTU JP, Goldblatt A, Rosas HD, Salat DH, et al
    White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  747. GAVETT BE, John SE, Gurnani AS, Bussell CA, et al
    The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  748. AGOSTINI S, Mancuso R, Baglio F, Cabinio M, et al
    Lack of Evidence for a Role of HHV-6 in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  749. PIERROT N, Lhommel R, Quenon L, Hanseeuw B, et al
    Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  750. CONEJERO-GOLDBERG C, Hyde TM, Chen S, Herman MM, et al
    Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  751. LIZIO R, Del Percio C, Marzano N, Soricelli A, et al
    Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  752. VALECH N, Mollica MA, Olives J, Tort A, et al
    Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal Aging.
    J Alzheimers Dis. 2015;48 Suppl 1:S87-98.
    PubMed     Text format     Abstract available


  753. WHITEHOUSE PJ, George DR
    A Tale of Two Reports: What Recent Publications from the Alzheimer's Association and Institute of Medicine say about the State of the Field.
    J Alzheimers Dis. 2015.
    PubMed     Text format    


  754. SUN X, Ma R, Yao X, Shang X, et al
    Concanavalin Agglutinin Levels are Decreased in Peripheral Blood of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  755. YOON B, Shim YS, Park HK, Park S, et al
    Predictive Factors for Disease Progression in Patients With Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  756. SAVASTANO A, Klafki H, Haussmann U, Oberstein TJ, et al
    N-Truncated Abeta 2-X Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  757. SPIEGEL J, Pirraglia E, Li Y, Tsui W, et al
    Greater Specificity for Cerebrospinal Fluid P-tau231 over P-tau181 in the Differentiation of Healthy Controls from Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  758. KIM HJ, Park KW, Kim TE, Im JY, et al
    Elevation of the Plasma Abeta40/Abeta 42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  759. SAVASTANO A, Klafki H, Haussmann U, Oberstein TJ, et al
    N-Truncated Abeta2-X Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models.
    J Alzheimers Dis. 2015;49:101-10.
    PubMed     Text format     Abstract available


  760. BRYNDIS EINARSDOTTIR A, Hardarson SH, Kristjansdottir JV, Bragason DT, et al
    Retinal Oximetry Imaging in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  761. TRIPLETT JC, Swomley AM, Cai J, Klein JB, et al
    Quantitative Phosphoproteomic Analyses of the Inferior Parietal Lobule from Three Different Pathological Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  762. LIU H, Qiu H, Xiao Q, Le W, et al
    Chronic Hypoxia-Induced Autophagy Aggravates the Neuropathology of Alzheimer's Disease through AMPK-mTOR Signaling in the APPSwe/PS1dE9 Mouse Model.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  763. SPARRE-SORENSEN M, Kristensen G
    Alzheimer's Disease in the Danish Malnutrition Period 1999-2007.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  764. MOON SW, Dinov ID, Kim J, Zamanyan A, et al
    Structural Neuroimaging Genetics Interactions in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  765. ZHENG W, Yao Z, Hu B, Gao X, et al
    Novel Cortical Thickness Pattern for Accurate Detection of Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  766. TORMALEHTO SM, Martikainen JA, Vaatainen ST, Hallikainen IT, et al
    Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  767. CALDERON-GARCIDUENAS L, Mora-Tiscareno A, Sanchez GM, Rodriguez-Diaz J, et al
    A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE varepsilon4 Mexico City Children and Their Parents.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  768. PRICE CC, Tanner JJ, Schmalfuss IM, Brumback B, et al
    Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  769. BIELARCZYK H, Jankowska-Kulawy A, Hofling C, Ronowska A, et al
    AbetaPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  770. MISTRIDIS P, Krumm S, Monsch AU, Berres M, et al
    The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  771. JHA NK, Jha SK, Kumar D, Kejriwal N, et al
    Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  772. GIACCONE G
    The Existence of Primary Age-Related Tauopathy Suggests that not all the Cases with Early Braak Stages of Neurofibrillary Pathology are Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  773. DIEHL-WIESENECKER E, von Armin CA, Dupuis L, Muller HP, et al
    Adipose Tissue Distribution in Patients with Alzheimer's Disease: A Whole Body MRI Case-Control Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  774. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:557-61.
    PubMed     Text format    


  775. REDDY PH, Blackmon J, Molinar-Lopez V, Ament C, et al
    Garrison Institute on Aging: A New Hope for Elderly Individuals and Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:547-55.
    PubMed     Text format     Abstract available


  776. WOOD PL, Medicherla S, Sheikh N, Terry B, et al
    Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer's Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:537-46.
    PubMed     Text format     Abstract available


  777. EL HAJ M, Gely-Nargeot MC, Raffard S
    Destination Memory and Cognitive Theory of Mind in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:529-36.
    PubMed     Text format     Abstract available


  778. SAMURAKI M, Matsunari I, Yoshita M, Shima K, et al
    Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:517-28.
    PubMed     Text format     Abstract available


  779. SARAJARVI T, Marttinen M, Natunen T, Kauppinen T, et al
    Genetic Variation in delta-Opioid Receptor Associates with Increased beta- and gamma-Secretase Activity in the Late Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:507-16.
    PubMed     Text format     Abstract available


  780. SARLUS H, Eyjolfsdottir H, Eriksdotter M, Oprica M, et al
    Influence of Allergy on Immunoglobulins and Amyloid-beta in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:495-505.
    PubMed     Text format     Abstract available


  781. GAUTHIER S, Rountree S, Finn B, LaPlante B, et al
    Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study.
    J Alzheimers Dis. 2015;48:473-81.
    PubMed     Text format     Abstract available


  782. LIAO X, Li G, Wang A, Liu T, et al
    Repetitive Transcranial Magnetic Stimulation as an Alternative Therapy for Cognitive Impairment in Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2015;48:463-72.
    PubMed     Text format     Abstract available


  783. LEIFERT WR, Nguyen T, Rembach A, Martins R, et al
    Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
    J Alzheimers Dis. 2015;48:443-52.
    PubMed     Text format     Abstract available


  784. LEWCZUK P, Kornhuber J, Toledo JB, Trojanowski JQ, et al
    Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects.
    J Alzheimers Dis. 2015;48:433-41.
    PubMed     Text format     Abstract available


  785. WEISE D, Tiepolt S, Awissus C, Hoffmann KT, et al
    Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
    J Alzheimers Dis. 2015;48:425-32.
    PubMed     Text format     Abstract available


  786. KEENEY JT, Ibrahimi S, Zhao L
    Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    J Alzheimers Dis. 2015;48:411-24.
    PubMed     Text format     Abstract available


  787. MATSUNAGA S, Kishi T, Annas P, Basun H, et al
    Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2015;48:403-10.
    PubMed     Text format     Abstract available


  788. SERVELLO A, Fioretti A, Gualdi G, Di Biasi C, et al
    Olfactory Dysfunction, Olfactory Bulb Volume and Alzheimer's Disease: Is There a Correlation? A Pilot Study1.
    J Alzheimers Dis. 2015;48:395-402.
    PubMed     Text format     Abstract available


  789. REA R, Carotenuto A, Traini E, Fasanaro AM, et al
    Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
    J Alzheimers Dis. 2015;48:377-83.
    PubMed     Text format     Abstract available


  790. BEYDOUN MA, Beydoun HA, Gamaldo AA, Rostant OS, et al
    Nationwide Inpatient Prevalence, Predictors, and Outcomes of Alzheimer's Disease among Older Adults in the United States, 2002-2012.
    J Alzheimers Dis. 2015;48:361-75.
    PubMed     Text format     Abstract available


  791. HARRIS SA, Harris EA
    Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:319-53.
    PubMed     Text format     Abstract available


  792. PISTOLLATO F, Cano SS, Elio I, Vergara MM, et al
    The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:303-18.
    PubMed     Text format     Abstract available


  793. DUBNER L, Wang J, Ho L, Ward L, et al
    Recommendations for Development of New Standardized Forms of Cocoa Breeds and Cocoa Extract Processing for the Prevention of Alzheimer's Disease: Role of Cocoa in Promotion of Cognitive Resilience and Healthy Brain Aging.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  794. POPOVA SN, Pesala S, Alafuzoff I
    To Stage Alzheimer's Disease Related Neurodegeneration Using one Section of Hippocampus.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  795. DI STEFANO F, Epelbaum S, Coley N, Cantet C, et al
    Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  796. DUITS FH, Hernandez-Guillamon M, Montaner J, Goos JD, et al
    Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  797. ERIKSDOTTER M, Vedin I, Falahati F, Freund-Levi Y, et al
    Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  798. YOU SC, Walsh CM, Chiodo LA, Ketelle R, et al
    Neuropsychiatric Symptoms Predict Functional Status in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  799. FORAKER J, Millard SP, Leong L, Thomson Z, et al
    The APOE Gene is Differentially Methylated in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  800. BILELLO M, Doshi J, Nabavizadeh SA, Toledo JB, et al
    Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  801. MAGISTRI M, Velmeshev D, Makhmutova M, Faghihi MA, et al
    Transcriptomics Profiling of Alzheimer's Disease Reveal Neurovascular Defects, Altered Amyloid-beta Homeostasis, and Deregulated Expression of Long Noncoding RNAs.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  802. KUBO M, Kishi T, Matsunaga S, Iwata N, et al
    Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  803. HONG HS, Maezawa I, Petrlova J, Zhao XY, et al
    Tomoregulin (TMEFF2) Binds Alzheimer's Disease Amyloid-beta (Abeta) Oligomer and AbetaPP and Protects Neurons from Abeta-Induced Toxicity.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  804. MEIER S, Bell M, Lyons DN, Ingram A, et al
    Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  805. GRAMUNT N, Buschke H, Sanchez-Benavides G, Lipton RB, et al
    Reference Data of the Spanish Memory Binding Test in a Midlife Population from the ALFA STUDY (Alzheimer's and Family).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  806. MENENDEZ-GONZALEZ M, de Celis Alonso B, Salas-Pacheco J, Arias-Carrion O, et al
    Structural Neuroimaging of the Medial Temporal Lobe in Alzheimer's Disease Clinical Trials.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  807. MATSUZONO K, Sato K, Kono S, Hishikawa N, et al
    Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS).
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


    August 2015

  808. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:287-91.
    PubMed     Text format    


  809. MATSUZONO K, Hishikawa N, Yamashita T, Ohta Y, et al
    Comprehensive Clinical Evaluations of Frontotemporal Dementia Contrasting to Alzheimer's Disease (oFTD Study).
    J Alzheimers Dis. 2015;48:279-86.
    PubMed     Text format     Abstract available


  810. ANDERKOVA L, Eliasova I, Marecek R, Janousova E, et al
    Distinct Pattern of Gray Matter Atrophy in Mild Alzheimer's Disease Impacts on Cognitive Outcomes of Noninvasive Brain Stimulation.
    J Alzheimers Dis. 2015;48:251-60.
    PubMed     Text format     Abstract available


  811. HEISKANEN J, Hartikainen S, Roine RP, Tolppanen AM, et al
    30-Day Mortality after Cardiovascular Events in Persons with or without Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:241-9.
    PubMed     Text format     Abstract available


  812. BRUEGGEN K, Dyrba M, Barkhof F, Hausner L, et al
    Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    J Alzheimers Dis. 2015;48:197-204.
    PubMed     Text format     Abstract available


  813. SCHMIDT C, Gerlach N, Schmitz M, Thom T, et al
    Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:189-96.
    PubMed     Text format     Abstract available


  814. LI QX, Villemagne VL, Doecke JD, Rembach A, et al
    Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-beta Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    J Alzheimers Dis. 2015;48:175-87.
    PubMed     Text format     Abstract available


  815. PAPUC E, Kurys-Denis E, Krupski W, Tatara M, et al
    Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer's Disease?
    J Alzheimers Dis. 2015;48:115-21.
    PubMed     Text format     Abstract available


  816. ZHANG XF, Zhao YF, Zhu SW, Huang WJ, et al
    CXCL1 Triggers Caspase-3 Dependent Tau Cleavage in Long-Term Neuronal Cultures and in the Hippocampus of Aged Mice: Implications in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:89-104.
    PubMed     Text format     Abstract available


  817. SNIR JA, Suchy M, Lawrence KS, Hudson RH, et al
    Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:73-87.
    PubMed     Text format     Abstract available


  818. SOLLVANDER S, Ekholm-Pettersson F, Brundin RM, Westman G, et al
    Increased Number of Plasma B Cells Producing Autoantibodies Against Abeta42 Protofibrils in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:63-72.
    PubMed     Text format     Abstract available


  819. SIARKOS KT, Katirtzoglou EA, Politis AM
    A Review of Pharmacological Treatments for Depression in Alzheimer's Disease.
    J Alzheimers Dis. 2015;48:15-34.
    PubMed     Text format     Abstract available


  820. WESSON ASHFORD J, Mahoney L, Burkett T
    A Role for Complementary and Integrative Medicine in Alzheimer's Disease Prevention.
    J Alzheimers Dis. 2015;48:13-4.
    PubMed     Text format     Abstract available


  821. KHALSA DS
    Stress, Meditation, and Alzheimer's Disease Prevention: Where The Evidence Stands.
    J Alzheimers Dis. 2015;48:1-12.
    PubMed     Text format     Abstract available


  822. SPALLETTA G, Long JD, Robinson RG, Trequattrini A, et al
    Longitudinal Neuropsychiatric Predictors of Death in Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  823. ABERG D, Johansson P, Isgaard J, Wallin A, et al
    Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available



  824. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:1079-84.
    PubMed     Text format    


  825. TRAVASSOS M, Santana I, Baldeiras I, Tsolaki M, et al
    Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-beta Levels in Patients with Alzheimer's Disease?
    J Alzheimers Dis. 2015;47:1069-78.
    PubMed     Text format     Abstract available


  826. ZHAN Y, Chen K, Wu X, Zhang D, et al
    Identification of Conversion from Normal Elderly Cognition to Alzheimer's Disease using Multimodal Support Vector Machine.
    J Alzheimers Dis. 2015;47:1057-67.
    PubMed     Text format     Abstract available


  827. LIU K, Chojnacki JE, Wade EE, Saathoff JM, et al
    Bivalent Compound 17MN Exerts Neuroprotection through Interaction at Multiple Sites in a Cellular Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:1021-33.
    PubMed     Text format     Abstract available


  828. GLEASON CE, Fischer BL, Dowling NM, Setchell KD, et al
    Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:1009-19.
    PubMed     Text format     Abstract available


  829. WEILER M, Agosta F, Canu E, Copetti M, et al
    Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    J Alzheimers Dis. 2015;47:995-1007.
    PubMed     Text format     Abstract available


  830. MENDEZ MF, Paholpak P, Lin A, Zhang JY, et al
    Prevalence of Traumatic Brain Injury in Early Versus Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:985-93.
    PubMed     Text format     Abstract available


  831. QUIROZ YT, Willment KC, Castrillon G, Muniz M, et al
    Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:955-64.
    PubMed     Text format     Abstract available


  832. FU Y, Zhao D, Pan B, Wang J, et al
    Proteomic Analysis of Protein Expression Throughout Disease Progression in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:915-26.
    PubMed     Text format     Abstract available


  833. LI G, Xiong K, Korff A, Pan C, et al
    Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Abeta42 and Tau.
    J Alzheimers Dis. 2015;47:883-7.
    PubMed     Text format     Abstract available


  834. CATANIA M, Di Fede G, Tonoli E, Benussi L, et al
    Mirror Image of the Amyloid-beta Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:877-81.
    PubMed     Text format     Abstract available


  835. ALONSO R, Pisa D, Rabano A, Rodal I, et al
    Cerebrospinal Fluid from Alzheimer's Disease Patients Contains Fungal Proteins and DNA.
    J Alzheimers Dis. 2015;47:873-6.
    PubMed     Text format     Abstract available


  836. NOVAIS F, Starkstein S
    Phenomenology of Depression in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:845-55.
    PubMed     Text format     Abstract available


  837. BANIK A, Brown RE, Bamburg J, Lahiri DK, et al
    Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?1.
    J Alzheimers Dis. 2015;47:815-43.
    PubMed     Text format     Abstract available



  838. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:787-91.
    PubMed     Text format    


  839. VALOTASSIOU V, Papatriantafyllou J, Sifakis N, Tzavara C, et al
    Clinical Evaluation of Brain Perfusion SPECT with Brodmann Areas Mapping in Early Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:773-85.
    PubMed     Text format     Abstract available


  840. BRADLEY-WHITMAN MA, Abner E, Lynn BC, Lovell MA, et al
    A Novel Plasma Based Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:761-71.
    PubMed     Text format     Abstract available


  841. CHIAM JT, Lunnon K, Voyle N, Proitsi P, et al
    No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:741-50.
    PubMed     Text format     Abstract available


  842. NORDBERG A, Kadir A, Andreasen N, Almkvist O, et al
    Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment.
    J Alzheimers Dis. 2015;47:691-704.
    PubMed     Text format     Abstract available


  843. JENSEN-DAHM C, Waldemar G, Staehelin Jensen T, Malmqvist L, et al
    Autonomic Dysfunction in Patients with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:681-9.
    PubMed     Text format     Abstract available


  844. TANG X, Holland D, Dale AM, Miller MI, et al
    APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.
    J Alzheimers Dis. 2015;47:645-60.
    PubMed     Text format     Abstract available


  845. CHO SJ, Yun SM, Lee DH, Jo C, et al
    Plasma SUMO1 Protein is Elevated in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:639-43.
    PubMed     Text format     Abstract available


  846. VIRK SA, Eslick GD
    Aluminum Levels in Brain, Serum, and Cerebrospinal Fluid are Higher in Alzheimer's Disease Cases than in Controls: A Series of Meta-Analyses.
    J Alzheimers Dis. 2015;47:629-38.
    PubMed     Text format     Abstract available


  847. NAKANO Y, Matsuzono K, Yamashita T, Ohta Y, et al
    Long-Term Efficacy of Galantamine in Alzheimer's Disease: The Okayama Galantamine Study (OGS).
    J Alzheimers Dis. 2015;47:609-17.
    PubMed     Text format     Abstract available


  848. WANG ZX, Tan L, Wang HF, Ma J, et al
    Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses.
    J Alzheimers Dis. 2015;47:565-81.
    PubMed     Text format     Abstract available


  849. TIEPOLT S, Patt M, Hoffmann KT, Schroeter ML, et al
    Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject.
    J Alzheimers Dis. 2015;47:539-43.
    PubMed     Text format     Abstract available


  850. FLORIS G, Di Stefano F, Cherchi MV, Costa G, et al
    Multiple Spontaneous Cerebral Microbleeds and Leukoencephalopathy in PSEN1-Associated Familial Alzheimer's Disease: Mirror of Cerebral Amyloid Angiopathy?
    J Alzheimers Dis. 2015;47:535-8.
    PubMed     Text format     Abstract available


    July 2015

  851. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:531-4.
    PubMed     Text format    


  852. GIIL LM, Kristoffersen EK, Vedeler CA, Aarsland D, et al
    Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:523-9.
    PubMed     Text format     Abstract available


  853. YIN RH, Tan L, Liu Y, Wang WY, et al
    Multimodal Voxel-Based Meta-Analysis of White Matter Abnormalities in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:495-507.
    PubMed     Text format     Abstract available


  854. MATSUZONO K, Yamashita T, Ohta Y, Hishikawa N, et al
    Clinical Benefits of Memantine Treatment for Alzheimer's Disease in the Okayama Memantine Study II (OMS II).
    J Alzheimers Dis. 2015;47:487-93.
    PubMed     Text format     Abstract available


  855. LEON C, Pin S, Kreft-Jais C, Arwidson P, et al
    Perceptions of Alzheimer's Disease in the French Population: Evolutions between 2008 and 2013 and Associated Factors in 2013.
    J Alzheimers Dis. 2015;47:467-78.
    PubMed     Text format     Abstract available


  856. RANGASAMY SB, Corbett GT, Roy A, Modi KK, et al
    Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:385-402.
    PubMed     Text format     Abstract available


  857. PIMENTEL LS, Allard S, Do Carmo S, Weinreb O, et al
    The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:373-83.
    PubMed     Text format     Abstract available


  858. HARTL D, Gu W, Mayhaus M, Pichler S, et al
    Amyloid-beta Protein Precursor Cleavage Products in Postmortem Ventricular Cerebrospinal Fluid of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2015;47:365-72.
    PubMed     Text format     Abstract available


  859. STEEL AJ, Eslick GD
    Herpes Viruses Increase the Risk of Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2015;47:351-64.
    PubMed     Text format     Abstract available


  860. ROMAN GC
    MTHFR Gene Mutations: A Potential Marker of Late-Onset Alzheimer's Disease?
    J Alzheimers Dis. 2015;47:323-7.
    PubMed     Text format     Abstract available


  861. LISTA S, O'Bryant SE, Blennow K, Dubois B, et al
    Biomarkers in Sporadic and Familial Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:291-317.
    PubMed     Text format     Abstract available


  862. KINCSES ZT, Kiraly A, Vereb D, Vecsei L, et al
    Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models.
    J Alzheimers Dis. 2015;47:277-90.
    PubMed     Text format     Abstract available



  863. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:273-6.
    PubMed     Text format    



  864. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
    J Alzheimers Dis. 2015;47:271.
    PubMed     Text format    


  865. VAN HARTEN AC, Mulders J, Scheltens P, van der Flier WM, et al
    Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:243-52.
    PubMed     Text format     Abstract available


  866. EDMONDS EC, Delano-Wood L, Galasko DR, Salmon DP, et al
    Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:231-42.
    PubMed     Text format     Abstract available


  867. LIU-SEIFERT H, Siemers E, Price K, Han B, et al
    Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:205-14.
    PubMed     Text format     Abstract available


  868. NAKAMAGOE K, Fujimiya S, Koganezawa T, Kadono K, et al
    Vestibular Function Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:185-96.
    PubMed     Text format     Abstract available


  869. BUSSE S, Steiner J, Alter J, Dobrowolny H, et al
    Expression of HLA-DR, CD80, and CD86 in Healthy Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:177-84.
    PubMed     Text format     Abstract available


  870. WANG Q, Jia J, Qin W, Wu L, et al
    A Novel AbetaPP M722K Mutation Affects Amyloid-beta Secretion and Tau Phosphorylation and May Cause Early-Onset Familial Alzheimer's Disease in Chinese Individuals.
    J Alzheimers Dis. 2015;47:157-65.
    PubMed     Text format     Abstract available


  871. WESSON ASHFORD J
    Treatment of Alzheimer's Disease: The Legacy of the Cholinergic Hypothesis, Neuroplasticity, and Future Directions.
    J Alzheimers Dis. 2015;47:149-56.
    PubMed     Text format     Abstract available


  872. WARING JF, Tang Q, Robieson WZ, King DP, et al
    APOE-varepsilon4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:137-48.
    PubMed     Text format     Abstract available


  873. JOHNSON LA, Gamboa A, Vintimilla R, Cheatwood AJ, et al
    Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans.
    J Alzheimers Dis. 2015;47:129-36.
    PubMed     Text format     Abstract available


  874. RUDNITSKAYA EA, Muraleva NA, Maksimova KY, Kiseleva E, et al
    Melatonin Attenuates Memory Impairment, Amyloid-beta Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:103-16.
    PubMed     Text format     Abstract available


  875. ATWOOD CS, Bowen RL
    A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2015;47:33-47.
    PubMed     Text format     Abstract available


  876. GROBLEWSKA M, Muszynski P, Wojtulewska-Supron A, Kulczynska-Przybik A, et al
    The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:17-32.
    PubMed     Text format     Abstract available


  877. MOOSAVI B, Mousavi B, Macreadie IG
    Yeast Model of Amyloid-beta and Tau Aggregation in Alzheimer's Disease.
    J Alzheimers Dis. 2015;47:9-16.
    PubMed     Text format     Abstract available


    June 2015

  878. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:1129-33.
    PubMed     Text format    


  879. GUSTAFSON DR, Clare Morris M, Scarmeas N, Shah RC, et al
    New Perspectives on Alzheimer's Disease and Nutrition.
    J Alzheimers Dis. 2015;46:1111-27.
    PubMed     Text format     Abstract available


  880. JONGBLOED W, van Dijk KD, Mulder SD, van de Berg WD, et al
    Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:1103-10.
    PubMed     Text format     Abstract available


  881. BURNHAM SC, Raghavan N, Wilson W, Baker D, et al
    Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study.
    J Alzheimers Dis. 2015;46:1079-89.
    PubMed     Text format     Abstract available


  882. WANG H, Tan L, Wang HF, Liu Y, et al
    Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2015;46:1049-70.
    PubMed     Text format     Abstract available


  883. ASSELINEAU D, Benlhassan K, Arosio B, Mari D, et al
    Interleukin-10 Production in Response to Amyloid-beta Differs between Slow and Fast Decliners in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:837-42.
    PubMed     Text format     Abstract available


  884. KHAN TK, Alkon DL
    Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.
    J Alzheimers Dis. 2015;46:817-36.
    PubMed     Text format     Abstract available



  885. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:813-6.
    PubMed     Text format    


  886. TEDONE E, Arosio B, Colombo F, Ferri E, et al
    Leukocyte Telomere Length in Alzheimer's Disease Patients with a Different Rate of Progression.
    J Alzheimers Dis. 2015;46:761-9.
    PubMed     Text format     Abstract available


  887. MATSUZONO K, Yamashita T, Ohta Y, Hishikawa N, et al
    Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS).
    J Alzheimers Dis. 2015;46:687-93.
    PubMed     Text format     Abstract available


  888. MOODLEY KK, Perani D, Minati L, Anthony Della Rosa P, et al
    Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
    J Alzheimers Dis. 2015;46:639-53.
    PubMed     Text format     Abstract available


    May 2015

  889. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:549-52.
    PubMed     Text format    


  890. WANG C, Tan L, Wang HF, Yu WJ, et al
    Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:491-5.
    PubMed     Text format     Abstract available


  891. TERNI B, Ferrer I
    Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer's Disease-Related Pathology.
    J Alzheimers Dis. 2015;46:461-9.
    PubMed     Text format     Abstract available



  892. Upcoming Meetings Related to Alzheimer's Disease.
    J Alzheimers Dis. 2015;46:285-7.
    PubMed     Text format    


    April 2015
  893. WURTMAN RJ
    How Anticholinergic Drugs Might Promote Alzheimer's Disease: More Amyloid-beta and Less Phosphatidylcholine.
    J Alzheimers Dis. 2015;46:983-7.
    PubMed     Text format     Abstract available


    January 2015
  894. PISTONO A, Jucla M, Barbeau EJ, Saint-Aubert L, et al
    Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer's Disease.
    J Alzheimers Dis. 2015.
    PubMed     Text format     Abstract available


  895. SHAKESPEARE TJ, Yong KX, Foxe D, Hodges J, et al
    Pronounced impairment of everyday skills and self-care in posterior cortical atrophy.
    J Alzheimers Dis. 2015;43:381-4.
    PubMed     Text format     Abstract available


  896. MADERNA E, Cattaneo C, Cacciatore F, Catania M, et al
    Divergent cognitive status with the same Braak stage of neurofibrillary pathology: does the pattern of amyloid-beta deposits make the difference?
    J Alzheimers Dis. 2015;43:375-9.
    PubMed     Text format     Abstract available


  897. TUCKER S, Moller C, Tegerstedt K, Lord A, et al
    The murine version of BAN2401 (mAb158) selectively reduces amyloid-beta protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.
    J Alzheimers Dis. 2015;43:575-88.
    PubMed     Text format     Abstract available


  898. SANTANGELO R, Coppi E, Ferrari L, Bernasconi MP, et al
    Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia.
    J Alzheimers Dis. 2015;43:1429-40.
    PubMed     Text format     Abstract available


  899. HAGHIGHI M, Smith A, Morgan D, Small B, et al
    Identifying cost-effective predictive rules of amyloid-beta level by integrating neuropsychological tests and plasma-based markers.
    J Alzheimers Dis. 2015;43:1261-70.
    PubMed     Text format     Abstract available


  900. ASO E, Sanchez-Pla A, Vegas-Lozano E, Maldonado R, et al
    Cannabis-based medicine reduces multiple pathological processes in AbetaPP/PS1 mice.
    J Alzheimers Dis. 2015;43:977-91.
    PubMed     Text format     Abstract available


  901. GIFFORD KA, Liu D, Damon SM, Chapman WG 4th, et al
    Subjective memory complaint only relates to verbal episodic memory performance in mild cognitive impairment.
    J Alzheimers Dis. 2015;44:309-18.
    PubMed     Text format     Abstract available


  902. KAWADA H, Blessing K, Kiyota T, Woolman T, et al
    Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-beta metal dyshomeostasis.
    J Alzheimers Dis. 2015;44:297-307.
    PubMed     Text format     Abstract available


  903. JOCHEMSEN HM, van der Flier WM, Ashby EL, Teunissen CE, et al
    Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy.
    J Alzheimers Dis. 2015;44:153-62.
    PubMed     Text format     Abstract available


  904. ECKERSTROM C, Olsson E, Klasson N, Berge J, et al
    Multimodal prediction of dementia with up to 10 years follow up: the Gothenburg MCI study.
    J Alzheimers Dis. 2015;44:205-14.
    PubMed     Text format     Abstract available


  905. SIECZKOWSKI E, Milenkovic I, Venkataramani V, Giera R, et al
    I716F AbetaPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-beta and alpha-synucleinopathy with Lewy bodies.
    J Alzheimers Dis. 2015;44:103-14.
    PubMed     Text format     Abstract available


  906. ROBB E, Perez K, Hung LW, Masters CL, et al
    High order W02-reactive stable oligomers of amyloid-beta are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-beta monomer.
    J Alzheimers Dis. 2015;44:69-78.
    PubMed     Text format     Abstract available


  907. MERRIL CR, Ghanbari HA
    Two hundred issues later: the dream comes true.
    J Alzheimers Dis. 2015;44:727-8.
    PubMed     Text format    


  908. PERRY G
    Two hundred treasured issues!
    J Alzheimers Dis. 2015;44:725.
    PubMed     Text format    


  909. BARRETT JP, Minogue AM, Jones RS, Ribeiro C, et al
    Bone marrow-derived macrophages from AbetaPP/PS1 mice are sensitized to the effects of inflammatory stimuli.
    J Alzheimers Dis. 2015;44:949-62.
    PubMed     Text format     Abstract available


  910. KIM HJ, Im K, Kwon H, Lee JM, et al
    Effects of amyloid and small vessel disease on white matter network disruption.
    J Alzheimers Dis. 2015;44:963-75.
    PubMed     Text format     Abstract available


  911. PUIG KL, Lutz BM, Urquhart SA, Rebel AA, et al
    Overexpression of mutant amyloid-beta protein precursor and presenilin 1 modulates enteric nervous system.
    J Alzheimers Dis. 2015;44:1263-78.
    PubMed     Text format     Abstract available


  912. ORDONEZ-GUTIERREZ L, Anton M, Wandosell F
    Peripheral amyloid levels present gender differences associated with aging in AbetaPP/PS1 mice.
    J Alzheimers Dis. 2015;44:1063-8.
    PubMed     Text format     Abstract available


  913. KOAL T, Klavins K, Seppi D, Kemmler G, et al
    Sphingomyelin SM(d18:1/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-beta42, tau, and phospho-tau-181 levels.
    J Alzheimers Dis. 2015;44:1193-201.
    PubMed     Text format     Abstract available


  914. LUNA-MUNOZ J, Perry G, Guevara J
    Raul Mena: 1953-2014.
    J Alzheimers Dis. 2015;45:325-7.
    PubMed     Text format    


  915. ITO K, Fukuyama H, Senda M, Ishii K, et al
    Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.
    J Alzheimers Dis. 2015;45:543-52.
    PubMed     Text format     Abstract available


  916. MEISSNER JN, Bouter Y, Bayer TA
    Neuron Loss and Behavioral Deficits in the TBA42 Mouse Model Expressing N-Truncated Pyroglutamate Amyloid-beta3-42.
    J Alzheimers Dis. 2015;45:471-82.
    PubMed     Text format     Abstract available


  917. STRUYFS H, Van Broeck B, Timmers M, Fransen E, et al
    Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-beta Isoforms for Early and Differential Dementia Diagnosis.
    J Alzheimers Dis. 2015;45:813-22.
    PubMed     Text format     Abstract available


  918. PENG L, Yu Y, Liu J, Li S, et al
    The chemerin receptor CMKLR1 is a functional receptor for amyloid-beta peptide.
    J Alzheimers Dis. 2015;43:227-42.
    PubMed     Text format     Abstract available


  919. UHM KO, Kim MJ, Kawaguchi M, Akatsu H, et al
    ATBF1 is a novel amyloid-beta protein precursor (AbetaPP) binding protein that affects AbetaPP expression.
    J Alzheimers Dis. 2015;43:243-57.
    PubMed     Text format     Abstract available


  920. LI JG, Pratico D
    High levels of homocysteine results in cerebral amyloid angiopathy in mice.
    J Alzheimers Dis. 2015;43:29-35.
    PubMed     Text format     Abstract available


  921. GOZES I, Yeheskel A, Pasmanik-Chor M
    Activity-dependent neuroprotective protein (ADNP): a case study for highly conserved chordata-specific genes shaping the brain and mutated in cancer.
    J Alzheimers Dis. 2015;45:57-73.
    PubMed     Text format     Abstract available


  922. SUN Y, Bresell A, Rantalainen M, Hoglund K, et al
    An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Abeta1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2015;45:1061-76.
    PubMed     Text format     Abstract available


  923. NIEMANTSVERDRIET E, Feyen BF, Le Bastard N, Martin JJ, et al
    Overdiagnosing Vascular Dementia using Structural Brain Imaging for Dementia Work-Up.
    J Alzheimers Dis. 2015;45:1039-43.
    PubMed     Text format     Abstract available


    January 2014
  924. VANGAVARAGU JR, Valasani KR, Fang D, Williams TD, et al
    Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics.
    J Alzheimers Dis. 2014;42:333-44.
    PubMed     Text format     Abstract available


  925. DE BRUIJN RF, Janssen JA, Brugts MP, van Duijn CM, et al
    Insulin-like growth factor-I receptor stimulating activity is associated with dementia.
    J Alzheimers Dis. 2014;42:137-42.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: